Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",2.7208759941455076e-07,3.591286307053942,54.289984225412745,"['GPR27', 'OXTR', 'NPFFR1', 'CHRM5', 'HTR2B', 'GPR83', 'ADRA1D', 'MCHR1', 'MC4R', 'HTR7', 'GPER1', 'DRD2', 'GPR34', 'P2RY14', 'NPY1R', 'OPRK1', 'NMBR', 'GPR3', 'SSTR1', 'ADRA2C', 'HTR5A', 'ADRA2A', 'HCRTR2', 'ADORA2A', 'LPAR6', 'ACKR4', 'OR6A2', 'RGL4', 'OR3A2']",0.0001452947780873701,0,0,29
2,Allograft Rejection WP2328,4.2060481097154955e-06,5.199144385026738,64.36014097378944,"['C1QB', 'C1QA', 'ABCB1', 'TGFB1', 'HLA-C', 'HLA-A', 'HLA-F', 'HLA-E', 'VEGFA', 'C3', 'CASP7', 'CASP8', 'C6', 'IL5', 'COL5A1', 'HLA-DRA']",0.0011230148452940373,0,0,16
3,Cytoplasmic Ribosomal Proteins WP477,1.0841857408447438e-05,3.055233291298865,34.92772098813742,"['RPL3', 'RPLP0', 'RPL10A', 'RPS15', 'RPL7A', 'RPS16', 'RPS15A', 'RPL18A', 'RPS18', 'RPL14', 'RPL38', 'RPL15', 'RPS27A', 'RPL18', 'RPL39', 'RPL17', 'RPS7', 'RPSA', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL26', 'FAU', 'RPS23']",0.001929850618703644,0,0,26
4,Peptide GPCRs WP24,0.0002844814353284397,4.6140417457305505,37.672924420106135,"['MC4R', 'OXTR', 'C5AR1', 'GNRHR', 'NPY1R', 'TAC4', 'OPRK1', 'SSTR1', 'NMBR', 'TSHR', 'HCRTR2']",0.0379782716163467,0,0,11
5,Development and heterogeneity of the ILC family WP3893,0.000935429972205184,8.540350877192983,59.56471366932721,"['IL5', 'NFIL3', 'IL7', 'IL18', 'AHR', 'TOX']",0.07622054926538598,0,0,6
6,Sleep regulation WP3591,0.0010558456710791076,4.579839317097665,31.387531454957102,"['CHRNB2', 'OXTR', 'AHCY', 'STAR', 'ADORA2A', 'IL18', 'CRH', 'DRD2', 'HCRTR2']",0.07622054926538598,0,0,9
7,Proximal tubule transport WP4917,0.0011528584094871207,3.4225352112676055,23.15519909630481,"['SLC47A2', 'ATP6V1G1', 'SLC22A6', 'ABCC2', 'ABCB1', 'SLC3A1', 'ATP6V0A4', 'ATP1B1', 'ATP6V0C', 'ATP6V1D', 'SLC26A6', 'AQP1']",0.07622054926538598,0,0,12
8,Spinal Cord Injury WP2431,0.001188463339026448,2.421650143907899,16.310041640239618,"['C1QB', 'EGR1', 'BTG2', 'TGFB1', 'CDKN1B', 'IL1R1', 'GADD45A', 'PDYN', 'PTGS2', 'AQP1', 'GFAP', 'TNFSF13B', 'LGALS3', 'NR4A1', 'CCND1', 'APEX1', 'SLIT3', 'LTB', 'ROS1', 'TLR4']",0.07622054926538598,0,0,20
9,TYROBP causal network in microglia WP3945,0.0012846159988548198,3.9589032174026313,26.355588332144762,"['APBB1IP', 'C3', 'RBM47', 'IGSF6', 'ADAP2', 'IL18', 'LHFPL2', 'SAMSN1', 'TMEM106A', 'ZFP36L2']",0.07622054926538598,0,0,10
10,Vitamin D Receptor Pathway WP2877,0.0017381761505488324,2.2730758916599623,14.445212956023386,"['ABCB1', 'TGFB1', 'CDKN1B', 'CDKN2C', 'IGFBP5', 'GADD45A', 'CDKN2A', 'SEMA3B', 'G0S2', 'ADAMTS5', 'CEACAM1', 'DUSP10', 'CCND1', 'CLMN', 'DND1', 'PNOC', 'TIMP2', 'TIMP3', 'SOSTDC1', 'LGALS9', 'JUNB']",0.07731704375747614,0,0,21
11,Glycolysis and Gluconeogenesis WP534,0.0017462266270823763,3.7502313815018202,23.815086961934295,"['LDHA', 'TPI1', 'PKM', 'GOT1', 'PGAM1', 'PGK1', 'ALDOC', 'ENO2', 'ALDOA', 'GCK']",0.07731704375747614,0,0,10
12,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.0018822501289273215,inf,inf,"['TGFB1', 'IL5', 'VIP']",0.07731704375747614,0,0,3
13,Gastric acid production WP2596,0.0018822501289273215,inf,inf,"['CCK', 'VIP', 'MUC6']",0.07731704375747614,0,0,3
14,Aryl Hydrocarbon Receptor Pathway WP2873,0.0020979955741763515,4.006700351493849,24.708411060086714,"['SLC7A5', 'HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'AIP', 'BAX', 'AHR', 'JUNB']",0.08002354547215512,0,0,9
15,Drug Induction of Bile Acid Pathway WP2289,0.002830817302851482,14.220794392523365,83.43609994177544,"['ABCB1', 'ABCC2', 'SLC10A1', 'SLC51A']",0.09550153689627039,0,0,4
16,Complement and Coagulation Cascades WP558,0.0028614692703002364,3.7707019538922775,22.082814544921476,"['C1QB', 'C3', 'C1QA', 'CPB2', 'C6', 'SERPIND1', 'C5AR1', 'MASP2', 'F5']",0.09550153689627039,0,0,9
17,Complement system WP2806,0.003074449451993617,2.949490043710539,17.06170692141621,"['C3', 'PRNP', 'FKBP2', 'C6', 'C5AR1', 'APOA1', 'C4BPA', 'MASP2', 'CD59', 'CALR', 'LRP2', 'DCN']",0.09657388278615243,0,0,12
18,Complement Activation WP545,0.004211685977642584,7.112799532437172,38.90624697928546,"['C1QB', 'C3', 'C1QA', 'C6', 'MASP2']",0.11972648911688998,0,0,5
19,Hypertrophy Model WP516,0.004374402738308906,5.33640350877193,28.987265336871868,"['NR4A3', 'MSTN', 'WDR1', 'IL1R1', 'IL18', 'VEGFA']",0.11972648911688998,0,0,6
20,Nuclear Receptors Meta-Pathway WP2882,0.0044841381691719095,1.6620985603543743,8.9873142286598,"['ABCB1', 'CDKN1B', 'SRXN1', 'ABCB4', 'SLC7A11', 'AHR', 'PTGS2', 'SLC5A3', 'CYP3A7', 'DNAJB1', 'RGS2', 'CCND1', 'SLC39A8', 'SLC39A7', 'JUNB', 'CBR3', 'SLC39A3', 'EGR1', 'JUN', 'HSP90AA1', 'GPX2', 'TGFB1', 'ABCC2', 'SLC10A1', 'SLC2A12', 'SLC39A11', 'AIP', 'APOA1', 'SLC39A13', 'SLC39A12', 'SLC2A9', 'SLC7A5', 'B3GNT5', 'MAFF', 'SPINK13', 'BAX', 'SPRY1', 'ANGPTL4', 'FKBP5']",0.11972648911688998,0,0,39
21,NAD Biosynthesis II (from tryptophan) WP2485,0.005959753963132031,9.4797507788162,48.56216654759112,"['TDO2', 'NMNAT1', 'HAAO', 'KMO']",0.1446594825596593,0,0,4
22,Role of Osx and miRNAs in tooth development WP3971,0.005959753963132031,9.4797507788162,48.56216654759112,"['NOTCH1', 'NOTCH4', 'DKK1', 'RUNX2']",0.1446594825596593,0,0,4
23,Monoamine GPCRs WP58,0.006312703927118591,3.5594262295081966,18.029174342199997,"['HTR7', 'CHRM5', 'HTR2B', 'ADRA1D', 'DRD2', 'HTR5A', 'ADRA2C', 'ADRA2A']",0.14656451726440556,0,0,8
24,Computational Model of Aerobic Glycolysis WP4629,0.006941908569115376,5.926845899084356,29.457482251954886,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA']",0.1544574656628171,0,0,5
25,Kynurenine Pathway and links to Cellular Senescence WP5044,0.009381191738019127,4.268421052631579,19.929464798221122,"['TDO2', 'HAAO', 'AHR', 'KMO', 'TLR4', 'ACMSD']",0.20038225552408856,0,0,6
26,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.010445823695199292,2.9125259626138362,13.285641620521808,"['LDHA', 'EDN1', 'ANGPT2', 'PKM', 'ANGPT1', 'PGK1', 'BAX', 'PTGS2', 'VEGFA']",0.20428355373326543,0,0,9
27,Unfolded protein response WP4925,0.01047285472470032,3.5579286132241075,16.220484948630702,"['PPP1R15A', 'XBP1', 'CASP8', 'HSPA5', 'DDIT3', 'TXNIP', 'BBC3']",0.20428355373326543,0,0,7
28,Cardiac Progenitor Differentiation WP2406,0.010711497199497063,3.163413999479573,14.35063024246552,"['MESP1', 'LIN28B', 'NOTCH1', 'TGFB1', 'TNNT2', 'ROR2', 'THY1', 'DKK1']",0.20428355373326543,0,0,8
29,Imatinib and Chronic Myeloid Leukemia WP3640,0.013008315998317038,3.8800637958532693,16.84788277558248,"['PDGFRB', 'SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'PIM2']",0.23953243941728616,0,0,6
30,Cori Cycle WP1946,0.015650045587851127,4.444403857393337,18.4766377083764,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA']",0.27447947381384485,0,0,5
31,IL-18 signaling pathway WP4754,0.015934201663350543,1.5718954248366013,6.506526976346919,"['SPON1', 'BTG2', 'CEBPB', 'RGS16', 'PTGS2', 'PLD1', 'RND2', 'ACACB', 'ADAMTS5', 'CASP8', 'TIMP3', 'IER3', 'JUN', 'TICAM2', 'USP5', 'PRKCD', 'FN1', 'IL18', 'BPGM', 'RUNX2', 'VEGFA', 'ACTA2', 'NR4A1', 'ARL4D', 'BMP2', 'RFX5', 'CYCS', 'BAX', 'LTB', 'NFKBIE', 'ITM2C', 'ARF6', 'MYH7']",0.27447947381384485,0,0,33
32,Selenium Micronutrient Network WP15,0.016582461403368255,2.249258710155671,9.220632938501875,"['SERPINA3', 'GPX2', 'SELENOM', 'RFK', 'DIO1', 'SELENOW', 'PNPO', 'APOA1', 'KMO', 'PTGS2', 'SEPHS2', 'SELENOH']",0.2747557315197983,0,0,12
33,Differentiation Pathway WP2848,0.017040061081614242,2.8466042154566744,11.591908019353673,"['NOTCH1', 'TGFB1', 'EGF', 'FST', 'FGF1', 'DKK1', 'VEGFA', 'FGF10']",0.2747557315197983,0,0,8
34,Cytokines and Inflammatory Response WP530,0.017493810621110755,5.686915887850467,23.008739278768292,"['TGFB1', 'IL5', 'IL7', 'HLA-DRA']",0.2747557315197983,0,0,4
35,NRF2 pathway WP2884,0.019946672061123532,1.8063248870555884,7.071207325223758,"['EGR1', 'HSP90AA1', 'GPX2', 'TGFB1', 'ABCC2', 'SRXN1', 'SLC2A12', 'SLC39A11', 'SLC39A13', 'SLC7A11', 'SLC39A12', 'SLC5A3', 'SLC2A9', 'DNAJB1', 'MAFF', 'SLC39A8', 'SLC39A7', 'SLC39A3', 'CBR3']",0.3043292251611419,0,0,19
36,Photodynamic therapy-induced unfolded protein response WP3613,0.022406229021859042,2.9293360410284652,11.126837700350565,"['PPP1R15A', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'BBC3']",0.33235906382424246,0,0,7
37,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.026348578570460524,4.738707165109035,17.231554912861455,"['NOTCH1', 'EPAS1', 'TCF7', 'VEGFA']",0.3802740799088086,0,0,4
38,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.02819303787138901,7.105662580268535,25.357837468309953,"['HEY1', 'VEGFC', 'VEGFA']",0.3855604665658525,0,0,3
39,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.02947159956072213,2.1164777680906712,7.45916229568795,"['VAV3', 'BEX3', 'CASP7', 'CDKN1B', 'HSPA5', 'PTK2B', 'APOE', 'YBX3', 'ETS1', 'CARD14', 'IER3']",0.3855604665658525,0,0,11
40,Zinc homeostasis WP3529,0.02948963031776413,3.047869674185464,10.739828941437533,"['SLC39A11', 'SLC39A8', 'SLC39A13', 'SLC39A7', 'SLC39A12', 'SLC39A3']",0.3855604665658525,0,0,6
41,Cholesterol Biosynthesis Pathway WP197,0.029602957170786433,3.5549386323787258,12.512961013060266,"['SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'DHCR7']",0.3855604665658525,0,0,5
42,VEGFA-VEGFR2 Signaling Pathway WP3888,0.032162382134274706,1.3276304452617635,4.563009769320201,"['TRAF3IP2', 'RPL10A', 'ETS1', 'HERPUD1', 'ACTG1', 'TUBB8', 'TUBA1C', 'RPS6KA5', 'RPL18A', 'CCND1', 'CHAC1', 'EPHB2', 'CGNL1', 'TMOD1', 'DUSP5', 'HSP90AA1', 'TRPC3', 'PRKCD', 'GAB1', 'DKK1', 'RCN1', 'RAB37', 'RHOJ', 'MMRN2', 'TXNIP', 'RPL26', 'ERG', 'ALDOA', 'FJX1', 'ARF6', 'KANK1', 'SET', 'NOTCH4', 'FOXO4', 'PTGS2', 'ACACB', 'APOLD1', 'LDHA', 'PGK1', 'DNAJB9', 'PTK2B', 'IGFBP7', 'MYH11', 'EGR1', 'JUN', 'EGR3', 'FN1', 'BMX', 'RAB11A', 'VEGFA', 'DNAJA1', 'NR4A1', 'BMP2', 'NR4A3', 'PTPN9', 'CYCS', 'HYOU1', 'PTPN6', 'CALR']",0.4089217157072069,0,0,59
43,Heart Development WP1591,0.03709635015328407,2.8444444444444446,9.370273259593732,"['BMP2', 'NOTCH1', 'HEY1', 'VEGFC', 'VEGFA', 'FGF10']",0.4442657192691556,0,0,6
44,Glycolysis in senescence WP5049,0.0374381224103221,4.061415220293725,13.342016150139642,"['LDHA', 'PKM', 'PGK1', 'ALDOC']",0.4442657192691556,0,0,4
45,Inflammatory Response Pathway WP453,0.0374381224103221,4.061415220293725,13.342016150139642,"['IL5', 'LAMB2', 'FN1', 'IL5RA']",0.4442657192691556,0,0,4
46,Metabolic reprogramming in colon cancer WP4290,0.04466503009514967,2.134446397188049,6.635064101149649,"['ACLY', 'LDHA', 'PKM', 'PGAM1', 'PGK1', 'PYCR1', 'PYCR2', 'PDHB', 'SLC16A3']",0.48896996785788993,0,0,9
47,Prader-Willi and Angelman Syndrome WP3998,0.04470721298539042,2.033160274660861,6.318290398977711,"['GABRR2', 'MAGEL2', 'CDKN2C', 'CCND1', 'DLX5', 'CDKN2A', 'NDN', 'GNRH1', 'TYR', 'GABRD']",0.48896996785788993,0,0,10
48,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.04486803075849552,5.328809106830122,16.540781987236187,"['CHI3L1', 'BAX', 'IL6ST']",0.48896996785788993,0,0,3
49,Mevalonate pathway WP3963,0.04486803075849552,5.328809106830122,16.540781987236187,"['HMGCS1', 'HMGCR', 'ACAT2']",0.48896996785788993,0,0,3
50,Nanomaterial induced apoptosis WP2507,0.049539012589857885,2.961961815702318,8.900679814568834,"['CASP7', 'ENDOG', 'CASP8', 'BAX', 'CYCS']",0.5024100072498583,0,0,5
51,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.049539012589857885,2.961961815702318,8.900679814568834,"['CYP26A1', 'ABCD2', 'ABCB1', 'ABCC2', 'ABCB4']",0.5024100072498583,0,0,5
52,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.04957156294868887,2.370587087965672,7.122044722081511,"['CASP7', 'HSP90AA1', 'CASP8', 'ACAP1', 'IL18', 'NLRC4', 'AAMP']",0.5024100072498583,0,0,7
53,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.05080550635110927,3.553446261682243,10.588383408343708,"['BMP2', 'SST', 'DKK1', 'DCN']",0.5024100072498583,0,0,4
54,Dopaminergic Neurogenesis WP2855,0.05080550635110927,3.553446261682243,10.588383408343708,"['TGFB1', 'ASCL1', 'SLC18A2', 'GLI2']",0.5024100072498583,0,0,4
55,Senescence and Autophagy in Cancer WP615,0.058064917977539945,1.6687334656084656,4.7495385414307885,"['GABARAPL1', 'JUN', 'CEBPB', 'TGFB1', 'CDKN1B', 'GSN', 'IGFBP5', 'CDKN2A', 'FN1', 'CXCL14', 'BMP2', 'MAP1LC3A', 'IGFBP7', 'IL6ST', 'SLC39A3']",0.5294583848332858,0,0,15
56,Lung fibrosis WP3624,0.05864646519883228,2.262646949305814,6.417382575426483,"['EDN1', 'CEBPB', 'TGFB1', 'IL5', 'EGF', 'FAM13A', 'FGF1']",0.5294583848332858,0,0,7
57,DNA damage response WP707,0.0631841552617258,1.8202550637659416,5.027001535245896,"['CDKN1B', 'CASP8', 'CCND1', 'CCNE2', 'GADD45A', 'CHEK2', 'CYCS', 'BAX', 'BBC3', 'GADD45G', 'RAD9A']",0.5294583848332858,0,0,11
58,Oncostatin M Signaling Pathway WP2374,0.0631841552617258,1.8202550637659416,5.027001535245896,"['EGR1', 'CASP7', 'CEBPB', 'CDKN1B', 'PRKCH', 'PRKCD', 'TIMP3', 'PTK2B', 'IL6ST', 'JUNB', 'VEGFA']",0.5294583848332858,0,0,11
59,HIF1A and PPARG regulation of glycolysis WP2456,0.0653327452405648,4.2626970227670755,11.629753920575013,"['LDHA', 'TPI1', 'GPD1']",0.5294583848332858,0,0,3
60,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.0653327452405648,4.2626970227670755,11.629753920575013,"['CCND1', 'EGF', 'FN1']",0.5294583848332858,0,0,3
61,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.0653327452405648,4.2626970227670755,11.629753920575013,"['ANXA2', 'APOA1', 'APOE']",0.5294583848332858,0,0,3
62,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.0653327452405648,4.2626970227670755,11.629753920575013,"['MMP25', 'HLA-DRA', 'CD247']",0.5294583848332858,0,0,3
63,Osteoblast differentiation WP4787,0.06573105113384808,1.604507042253521,4.367763149841576,"['PRKCH', 'NOTCH1', 'NOTCH4', 'PRKCD', 'WNT8A', 'FGF1', 'WNT16', 'RUNX2', 'GLI3', 'GLI2', 'DLL3', 'BMP2', 'HEY1', 'BMPR1B', 'FGFR4', 'FGF10']",0.5294583848332858,0,0,16
64,Major receptors targeted by epinephrine and norepinephrine WP4589,0.06643017187983173,3.1583592938733127,8.564219473384076,"['ADCY10', 'ADRA1D', 'ADRA2C', 'ADRA2A']",0.5294583848332858,0,0,4
65,Matrix Metalloproteinases WP129,0.06643017187983173,3.1583592938733127,8.564219473384076,"['MMP25', 'TIMP2', 'TIMP3', 'MMP21']",0.5294583848332858,0,0,4
66,Phytochemical activity on NRF2 transcriptional activation WP3,0.06643017187983173,3.1583592938733127,8.564219473384076,"['AIMP2', 'CEBPB', 'SLC7A11', 'EPHB2']",0.5294583848332858,0,0,4
67,Tryptophan catabolism leading to NAD+ production WP4210,0.06643017187983173,3.1583592938733127,8.564219473384076,"['NMNAT1', 'TDO2', 'HAAO', 'KMO']",0.5294583848332858,0,0,4
68,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.07072974506017107,1.4995034756703078,3.972018370653108,"['CHRNB2', 'EGR1', 'DLX2', 'JUN', 'CEBPB', 'CAV3', 'CDCA7L', 'ATP1A3', 'SSTR1', 'ASCL1', 'GCK', 'VEGFA', 'PRKAR1A', 'SST', 'KCNQ1', 'PAH', 'CHRFAM7A', 'TAC1', 'ALDOA', 'YWHAG']",0.5485099320363276,0,0,20
69,Apoptosis Modulation and Signaling WP1772,0.0708748788586266,1.6821651630811936,4.452420738525507,"['JUN', 'ENDOG', 'CRADD', 'IL1R1', 'CDKN2A', 'PTPN13', 'BBC3', 'CASP7', 'CASP8', 'CYCS', 'BAX', 'BMF', 'BCL2L2']",0.5485099320363276,0,0,13
70,Ovarian infertility WP34,0.07574020127540522,2.5384069466477417,6.550222557145024,"['EGR1', 'CEBPB', 'CDKN1B', 'MSH5', 'BMPR1B']",0.5493355616619412,0,0,5
71,Cells and molecules involved in local acute inflammatory response  WP4493,0.07715387101993557,7.102100350058343,18.195251035183688,"['C3', 'C6']",0.5493355616619412,0,0,2
72,Codeine and Morphine Metabolism WP1604,0.07715387101993557,7.102100350058343,18.195251035183688,"['ABCB1', 'ABCC2']",0.5493355616619412,0,0,2
73,Composition of Lipid Particles WP3601,0.07715387101993557,7.102100350058343,18.195251035183688,"['APOA1', 'APOE']",0.5493355616619412,0,0,2
74,Nucleotide GPCRs WP80,0.07715387101993557,7.102100350058343,18.195251035183688,"['ADORA2A', 'LPAR6']",0.5493355616619412,0,0,2
75,Platelet-mediated interactions with vascular and circulating cells WP4462,0.07715387101993557,7.102100350058343,18.195251035183688,"['TGFB1', 'TLR4']",0.5493355616619412,0,0,2
76,miRNA regulation of DNA damage response WP1530,0.07845975847547028,1.739068100358423,4.426222942277162,"['CDKN1B', 'CASP8', 'CCND1', 'CCNE2', 'GADD45A', 'CHEK2', 'CYCS', 'BAX', 'BBC3', 'GADD45G', 'RAD9A']",0.5512830398144886,0,0,11
77,Differentiation of white and brown adipocyte WP2895,0.08423653388115275,2.842289719626168,7.032184480184484,"['CEBPB', 'BMP2', 'ZIC1', 'PRDM16']",0.5766962704171227,0,0,4
78,TP53 network WP1742,0.08423653388115275,2.842289719626168,7.032184480184484,"['CDKN2A', 'GADD45A', 'BAX', 'BBC3']",0.5766962704171227,0,0,4
79,Acute viral myocarditis WP4298,0.0868938603769425,1.7011220196353436,4.155956601507394,"['CASP7', 'EDN1', 'SGCD', 'CASP8', 'ENDOG', 'TGFB1', 'CCND1', 'CYCS', 'BAX', 'TLR4', 'SGCG']",0.5824571613333215,0,0,11
80,EDA signaling in hair follicle development WP3930,0.08925223529445883,3.5519556333917106,8.582550662373174,"['SOSTDC1', 'LTB', 'DKK1']",0.5824571613333215,0,0,3
81,Farnesoid X receptor pathway WP2879,0.08925223529445883,3.5519556333917106,8.582550662373174,"['SLC10A1', 'ABCB4', 'FKBP5']",0.5824571613333215,0,0,3
82,Canonical and non-canonical Notch signaling WP3845,0.09115706848742723,2.3689849990259106,5.674124721085519,"['NOTCH1', 'HEY1', 'NOTCH4', 'DLL3', 'DLK2']",0.5824571613333215,0,0,5
83,Striated Muscle Contraction Pathway WP383,0.09115706848742723,2.3689849990259106,5.674124721085519,"['TMOD1', 'ACTA2', 'MYOM1', 'TNNT2', 'ACTG1']",0.5824571613333215,0,0,5
84,Development of ureteric collection system WP5053,0.09162247481647755,1.9906377998829725,4.757780963388417,"['SALL1', 'CCND1', 'SPRY1', 'ETV4', 'GLI3', 'FREM2', 'GLI2']",0.5824571613333215,0,0,7
85,Genes controlling nephrogenesis WP4823,0.09272398685760597,2.132456140350877,5.071253830957831,"['PDGFRB', 'EMX2', 'LAMB2', 'ETV4', 'GLI3', 'VEGFA']",0.5825248115524893,0,0,6
86,Mitochondrial complex III assembly WP4921,0.10410330199462653,2.5836873406966867,5.845260822605982,"['UQCRB', 'UQCC3', 'UQCR10', 'CYC1']",0.6342316827698209,0,0,4
87,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.10410330199462653,2.5836873406966867,5.845260822605982,"['CCND1', 'PTGS2', 'BCL2L2', 'VEGFA']",0.6342316827698209,0,0,4
88,Oxidative Damage WP3941,0.10451758068116898,1.9139172705585812,4.322390736161827,"['C1QB', 'C1QA', 'CDKN1B', 'GADD45A', 'C5AR1', 'CYCS', 'NFKBIE']",0.6342316827698209,0,0,7
89,Microglia Pathogen Phagocytosis Pathway WP3937,0.10805105210806558,2.220740794856809,4.941484619388412,"['C1QB', 'VAV3', 'C1QA', 'HCK', 'PTPN6']",0.6411029091745225,0,0,5
90,Vitamin B12 metabolism WP1533,0.10805105210806558,2.220740794856809,4.941484619388412,"['SERPINA3', 'CUBN', 'APOA1', 'LRP2', 'APOE']",0.6411029091745225,0,0,5
91,miR-509-3p alteration of YAP1/ECM axis WP3967,0.11621096380921152,3.044283212409307,6.552357145763594,"['COL5A1', 'PBX3', 'FN1']",0.6717523944000053,0,0,3
92,ACE Inhibitor Pathway WP554,0.11824854882696723,4.7343446129910545,10.107667260687842,"['TGFB1', 'ATP6AP2']",0.6717523944000053,0,0,2
93,Metabolism of alpha-linolenic acid WP4586,0.11824854882696723,4.7343446129910545,10.107667260687842,"['ALOX12', 'PTGS2']",0.6717523944000053,0,0,2
94,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.11824854882696723,4.7343446129910545,10.107667260687842,"['NOTCH1', 'DLL3']",0.6717523944000053,0,0,2
95,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.12353296533249285,inf,inf,['FMO5'],0.6793321541754442,0,0,1
96,"GPCRs, Other WP117",0.12587172178311606,1.7233695266482152,3.5716695082742946,"['HTR7', 'ADGRV1', 'ADORA2A', 'ADGRF5', 'GNRHR', 'ADRA1D', 'GPR83', 'MCHR2']",0.6793321541754442,0,0,8
97,Pregnane X receptor pathway WP2876,0.12587285314105454,2.3681853582554515,4.9080238569288746,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A7']",0.6793321541754442,0,0,4
98,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.12587285314105454,2.3681853582554515,4.9080238569288746,"['BMP2', 'TGFB1', 'FN1', 'IGFBP7']",0.6793321541754442,0,0,4
99,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.12594360161679585,1.564516129032258,3.241553945320268,"['SFRP4', 'JUN', 'FRAT2', 'SFRP2', 'CCND1', 'TCF7', 'ROR2', 'NOTUM', 'WNT16', 'DKK1', 'CXXC4']",0.6793321541754442,0,0,11
100,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.1457507935149662,2.6635288966725046,5.129575795422327,"['BMP2', 'BMPR1B', 'RUNX2']",0.770603205316752,0,0,3
101,Cancer immunotherapy by PD-1 blockade WP4585,0.1457507935149662,2.6635288966725046,5.129575795422327,"['JUN', 'HLA-A', 'PDCD1LG2']",0.770603205316752,0,0,3
102,Hedgehog Signaling Pathway WP4249,0.14860550703060124,1.7155021085127418,3.2705363006905106,"['EVC', 'CCND1', 'HHIP', 'BOC', 'LRP2', 'GLI3', 'GLI2']",0.774352868589511,0,0,7
103,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.14936019749947496,2.1858375269590224,4.156139358634172,"['ITGB4', 'BAX', 'BCL2L14', 'BCL2L2']",0.774352868589511,0,0,4
104,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.16327632829021593,3.5504667444574096,6.43455081638856,"['APOE', 'TLR4']",0.7999042138254616,0,0,2
105,Biogenic Amine Synthesis WP550,0.16327632829021593,3.5504667444574096,6.43455081638856,"['GAD1', 'PAH']",0.7999042138254616,0,0,2
106,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.16327632829021593,3.5504667444574096,6.43455081638856,"['HSD11B1', 'STAR']",0.7999042138254616,0,0,2
107,Peroxiredoxin 2 induced ovarian failure WP4873,0.16327632829021593,3.5504667444574096,6.43455081638856,"['STAR', 'BAX']",0.7999042138254616,0,0,2
108,PTF1A related regulatory pathway WP4147,0.16327632829021593,3.5504667444574096,6.43455081638856,"['NOTCH1', 'FGF10']",0.7999042138254616,0,0,2
109,Urea cycle and related diseases WP4571,0.16327632829021593,3.5504667444574096,6.43455081638856,"['SLC25A15', 'CPS1']",0.7999042138254616,0,0,2
110,G1 to S cell cycle control WP45,0.17173794368109743,1.5230981672106452,2.6833723380366985,"['CREB3', 'CDKN1B', 'CDKN2C', 'CCND1', 'CCNE2', 'CDKN2A', 'GADD45A', 'RPA3', 'POLE2']",0.8237494798170227,0,0,9
111,Galanin receptor pathway WP4970,0.17739923254486445,2.3673866510994355,4.094046106982027,"['CDKN1B', 'PRKCD', 'VEGFA']",0.8237494798170227,0,0,3
112,Genes targeted by miRNAs in adipocytes WP1992,0.17739923254486445,2.3673866510994355,4.094046106982027,"['KCNE1', 'KCNQ1', 'ERG']",0.8237494798170227,0,0,3
113,ID signaling pathway WP53,0.17739923254486445,2.3673866510994355,4.094046106982027,"['PAX8', 'ID3', 'ELK3']",0.8237494798170227,0,0,3
114,IL1 and megakaryocytes in obesity WP2865,0.17739923254486445,2.3673866510994355,4.094046106982027,"['IL1R1', 'IL18', 'TIMP2']",0.8237494798170227,0,0,3
115,Overview of nanoparticle effects WP3287,0.17739923254486445,2.3673866510994355,4.094046106982027,"['FN1', 'BAX', 'PTGS2']",0.8237494798170227,0,0,3
116,Breast cancer pathway WP4262,0.18243797730651246,1.3063748467584915,2.222594332074411,"['SHC4', 'JUN', 'NOTCH1', 'SHC3', 'GADD45A', 'EGF', 'NOTCH4', 'TCF7', 'FGF1', 'WNT16', 'GADD45G', 'DLL3', 'SFRP4', 'FRAT2', 'CCND1', 'HEY1', 'BAX', 'FGF10']",0.8398437920834281,0,0,18
117,Pathways in clear cell renal cell carcinoma WP4018,0.18501925664534985,1.3985222812283538,2.3597201690437126,"['PDGFRB', 'ACLY', 'LDHA', 'TPI1', 'PKM', 'TGFB1', 'PGK1', 'ALDOC', 'ENO2', 'ALDOA', 'ACACB', 'VEGFA']",0.8444468636633916,0,0,12
118,Myometrial relaxation and contraction pathways WP289,0.19879205746725062,1.274785692843086,2.0594111085266746,"['OXTR', 'JUN', 'PRKCH', 'IGFBP5', 'RGS16', 'PRKCD', 'ACTG1', 'RGS4', 'ACTA2', 'RGS5', 'CREB3', 'RGS2', 'PRKAR1A', 'MAFF', 'CRH', 'CALM3', 'ATF5', 'YWHAG', 'CORIN']",0.8749145876366256,0,0,19
119,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.20066019302817245,1.8940809968847352,3.042163766914037,"['LDHA', 'PDHB', 'ACACB', 'VEGFA']",0.8749145876366256,0,0,4
120,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.20066019302817245,1.8940809968847352,3.042163766914037,"['CASP7', 'CASP8', 'BAX', 'BBC3']",0.8749145876366256,0,0,4
121,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.20066019302817245,1.8940809968847352,3.042163766914037,"['JUN', 'ABCC2', 'SRXN1', 'ABCC6']",0.8749145876366256,0,0,4
122,Statin inhibition of cholesterol production WP430,0.20066019302817245,1.8940809968847352,3.042163766914037,"['SQLE', 'APOA1', 'HMGCR', 'APOE']",0.8749145876366256,0,0,4
123,Exercise-induced Circadian Regulation WP410,0.2015252701859643,1.4959940835695797,2.3963439035014007,"['PER2', 'DNAJA1', 'DAZAP2', 'CLDN5', 'CEBPB', 'RBPMS', 'G0S2', 'HERPUD1']",0.8749145876366256,0,0,8
124,Aspirin and miRNAs WP4707,0.21063966002093518,2.8401400233372227,4.423820214264307,"['PTGS2', 'VEGFA']",0.8753606911569286,0,0,2
125,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.21063966002093518,2.8401400233372227,4.423820214264307,"['DHCR24', 'DHCR7']",0.8753606911569286,0,0,2
126,NOTCH1 regulation of endothelial cell calcification WP3413,0.21068995674385022,2.130472854640981,3.317929450718343,"['NOTCH1', 'VEGFA', 'DLL3']",0.8753606911569286,0,0,3
127,Corticotropin-releasing hormone signaling pathway WP2355,0.21072298053388183,1.3539011848871003,2.108309677977403,"['CRHBP', 'NR4A1', 'HSP90AA1', 'TGFB1', 'STAR', 'PRKCD', 'IL18', 'CRH', 'FOSB', 'JUNB', 'TLR4', 'FOSL2']",0.8753606911569286,0,0,12
128,Pre-implantation embryo WP3527,0.21146353775139284,1.6912972085385878,2.6277730287480696,"['EGR1', 'DLX2', 'DDIT3', 'FOSB', 'ZFP36L2']",0.8753606911569286,0,0,5
129,Tryptophan metabolism WP465,0.21146353775139284,1.6912972085385878,2.6277730287480696,"['TDO2', 'HAAO', 'DHCR24', 'CYP2C18', 'ACMSD']",0.8753606911569286,0,0,5
130,Genotoxicity pathway WP4286,0.21849925653365643,1.4575151624331952,2.2168407238634393,"['ACTA2', 'PLK3', 'BTG2', 'MEX3B', 'RPS27', 'GADD45A', 'PCDH8', 'TRIM22']",0.8756089322239202,0,0,8
131,Adipogenesis WP236,0.22505878049769254,1.284715581904337,1.9160166792028814,"['GDF10', 'CEBPB', 'TGFB1', 'EPAS1', 'GADD45A', 'EBF1', 'AHR', 'SFRP4', 'CYP26A1', 'BMP2', 'DDIT3', 'NDN', 'ID3', 'IL6ST', 'PCK2']",0.8756089322239202,0,0,15
132,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.22754765990661044,1.3478309232480534,1.995322925778721,"['SFRP4', 'JUN', 'FRAT2', 'SFRP2', 'CCND1', 'TCF7', 'ROR2', 'NOTUM', 'WNT16', 'DKK1', 'CXXC4']",0.8756089322239202,0,0,11
133,miRNA regulation of p53 pathway in prostate cancer WP3982,0.22803597645108378,1.7755549065420562,2.6247173627004594,"['CASP8', 'CHEK2', 'BAX', 'BBC3']",0.8756089322239202,0,0,4
134,Urea cycle and associated pathways WP4595,0.22803597645108378,1.7755549065420562,2.6247173627004594,"['SLC25A15', 'GOT1', 'CPS1', 'PYCR1']",0.8756089322239202,0,0,4
135,COVID-19 adverse outcome pathway WP4891,0.2318134148044373,7.098542274052478,10.376808653183996,['IL7'],0.8756089322239202,0,0,1
136,Thyroxine (Thyroid Hormone) Production WP1981,0.2318134148044373,7.098542274052478,10.376808653183996,['TSHR'],0.8756089322239202,0,0,1
137,Neovascularisation processes WP4331,0.23511958411528164,1.6142872323468467,2.336940710540766,"['NOTCH1', 'TGFB1', 'ANGPT1', 'NOTCH4', 'EPHB2']",0.8756089322239202,0,0,5
138,Glucocorticoid Receptor Pathway WP2880,0.23598305237258144,1.42096018735363,2.0518598157070533,"['RGS2', 'HSP90AA1', 'JUN', 'B3GNT5', 'SPINK13', 'SPRY1', 'ANGPTL4', 'PTGS2']",0.8756089322239202,0,0,8
139,Phosphodiesterases in neuronal function WP4222,0.23598305237258144,1.42096018735363,2.0518598157070533,"['ADCY10', 'PDE10A', 'ADORA2A', 'PDE6C', 'PDE5A', 'PDE6B', 'CHRFAM7A', 'DRD2']",0.8756089322239202,0,0,8
140,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.23598305237258144,1.42096018735363,2.0518598157070533,"['CEBPB', 'BMP2', 'NOTCH1', 'TGFB1', 'MSTN', 'TCF7', 'JUNB', 'RUNX2']",0.8756089322239202,0,0,8
141,Bladder cancer WP2828,0.23752608760270677,1.5221804511278196,2.1881006350146657,"['RPS6KA5', 'CCND1', 'EGF', 'CDKN2A', 'DAPK2', 'VEGFA']",0.8756089322239202,0,0,6
142,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.23752608760270677,1.5221804511278196,2.1881006350146657,"['IFITM3', 'JUN', 'IFITM2', 'IFI27', 'DDIT3', 'JUNB']",0.8756089322239202,0,0,6
143,ERK Pathway in Huntington's Disease WP3853,0.2451772561662372,1.936634293902245,2.7224698192559447,"['CASP7', 'RPS6KA5', 'EGF']",0.8756089322239202,0,0,3
144,GDNF/RET signaling axis WP4830,0.2451772561662372,1.936634293902245,2.7224698192559447,"['SALL1', 'SPRY1', 'GLI3']",0.8756089322239202,0,0,3
145,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.2451772561662372,1.936634293902245,2.7224698192559447,"['TGFB1', 'FN1', 'RUNX2']",0.8756089322239202,0,0,3
146,Apoptosis WP254,0.24627145666786518,1.3406622575150966,1.8786979998025808,"['CASP7', 'JUN', 'CASP8', 'CRADD', 'CDKN2A', 'CYCS', 'BAX', 'NFKBIE', 'BCL2L2', 'BBC3']",0.8756089322239202,0,0,10
147,Metapathway biotransformation Phase I and II WP702,0.24940487007615256,1.2542794895736071,1.741789980264816,"['CHST8', 'CHST9', 'GPX2', 'HS3ST3A1', 'NNMT', 'KCNAB1', 'GLYAT', 'CYP2C18', 'FMO5', 'CYP3A7', 'CYP26A1', 'GAL3ST2', 'SULT4A1', 'GAL3ST3', 'CHST2']",0.8756089322239202,0,0,15
148,Angiogenesis WP1539,0.25626772358515054,1.670973062122045,2.2750842739244193,"['ANGPT1', 'TIMP2', 'TIMP3', 'VEGFA']",0.8756089322239202,0,0,4
149,Gastric Cancer Network 1 WP2361,0.25626772358515054,1.670973062122045,2.2750842739244193,"['NOTCH1', 'GATD3B', 'GATD3A', 'KIF15']",0.8756089322239202,0,0,4
150,IL-7 signaling pathway WP205,0.25626772358515054,1.670973062122045,2.2750842739244193,"['CDKN1B', 'CCND1', 'IL7', 'PTK2B']",0.8756089322239202,0,0,4
151,NRF2-ARE regulation WP4357,0.25626772358515054,1.670973062122045,2.2750842739244193,"['AIMP2', 'CEBPB', 'SLC7A11', 'EPHB2']",0.8756089322239202,0,0,4
152,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.25702884119707337,1.4207138677589233,1.9301349456777104,"['SQLE', 'HMGCS1', 'ACOT2', 'MSMO1', 'DHCR24', 'HMGCR', 'DHCR7']",0.8756089322239202,0,0,7
153,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.25702884119707337,1.4207138677589233,1.9301349456777104,"['HSP90AA1', 'JUN', 'CCND1', 'CDKN2A', 'BAX', 'BMF', 'JUNB']",0.8756089322239202,0,0,7
154,Bile acids synthesis and enterohepatic circulation  WP4389,0.25907530204378165,2.366588875923765,3.1964013590523077,"['SLC10A1', 'FGFR4']",0.8756089322239202,0,0,2
155,Blood Clotting Cascade WP272,0.25907530204378165,2.366588875923765,3.1964013590523077,"['F8A1', 'F5']",0.8756089322239202,0,0,2
156,"Degradation pathway of sphingolipids, including diseases WP4153",0.25907530204378165,2.366588875923765,3.1964013590523077,"['NEU1', 'GLA']",0.8756089322239202,0,0,2
157,Selective expression of chemokine receptors during T-cell polarization WP4494,0.25907530204378165,2.366588875923765,3.1964013590523077,"['TGFB1', 'IL5']",0.8756089322239202,0,0,2
158,Trans-sulfuration pathway WP2333,0.25907530204378165,2.366588875923765,3.1964013590523077,"['AHCY', 'GOT1']",0.8756089322239202,0,0,2
159,Small cell lung cancer WP4658,0.27428011583417744,1.2482979162368475,1.6148048931030192,"['CDKN1B', 'LAMB3', 'LAMB2', 'GADD45A', 'LAMB4', 'FN1', 'PTGS2', 'GADD45G', 'CASP8', 'CCND1', 'CCNE2', 'CYCS', 'BAX']",0.9157799510067238,0,0,13
160,Focal Adhesion WP306,0.27897532862957053,1.1678550333305207,1.4909210239017125,"['VAV3', 'PDGFRB', 'SHC4', 'JUN', 'SHC3', 'CAV3', 'LAMB3', 'ITGB4', 'EGF', 'LAMB2', 'STYK1', 'FN1', 'TESK2', 'VEGFC', 'THBS4', 'VEGFA', 'ACTG1', 'MYL5', 'HCK', 'PPP1CC', 'RELN', 'CCND1', 'PDGFD']",0.9157799510067238,0,0,23
161,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.2804457436149342,1.7751021599532983,2.2568205088353825,"['HPGD', 'TRPA1', 'ALOX12']",0.9157799510067238,0,0,3
162,Eicosanoid Synthesis WP167,0.2804457436149342,1.7751021599532983,2.2568205088353825,"['PTGES2', 'ALOX12', 'PTGS2']",0.9157799510067238,0,0,3
163,Ferroptosis WP4313,0.2812507714702298,1.42046783625731,1.8018756414036357,"['PRNP', 'MAP1LC3A', 'ACSL5', 'SLC39A8', 'SLC7A11', 'CP']",0.9157799510067238,0,0,6
164,Hepatitis C and Hepatocellular Carcinoma WP3646,0.2812507714702298,1.42046783625731,1.8018756414036357,"['CASP7', 'JUN', 'TGFB1', 'CCND1', 'PTGS2', 'VEGFA']",0.9157799510067238,0,0,6
165,7-oxo-C and 7beta-HC pathways WP5064,0.2851392836847989,1.5780114226375908,1.9800532332529854,"['HSD11B1', 'ACOT2', 'DHCR7', 'ACOT6']",0.9228144090162582,0,0,4
166,Wnt signaling WP428,0.28834620094188085,1.2315521628498727,1.5315501835580274,"['JUN', 'TCF7', 'WNT16', 'DKK1', 'CXXC4', 'SFRP4', 'FRAT2', 'SFRP2', 'PPP3R2', 'CCND1', 'ROR2', 'GPC4', 'NOTUM']",0.9275715138732794,0,0,13
167,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.30221066876835156,1.2785588752196837,1.5299630909262876,"['MYO1E', 'CDKN1B', 'NOTCH1', 'TGFB1', 'ITGB4', 'LAMB2', 'FAT1', 'DKK1', 'TLR4']",0.9586283511893411,0,0,9
168,Osteoclast Signaling WP12,0.30759617484048685,2.0283380563427236,2.3913446006414714,"['AIMP2', 'ATP6V1G1']",0.9586283511893411,0,0,2
169,Alpha 6 Beta 4 signaling pathway WP244,0.30967106683852785,1.4202220923436586,1.6648477063239604,"['LAMB3', 'ITGB4', 'LAMB2', 'PRKCD', 'GAB1']",0.9586283511893411,0,0,5
170,Base Excision Repair WP4752,0.30967106683852785,1.4202220923436586,1.6648477063239604,"['FEN1', 'NEIL2', 'APEX1', 'POLE2', 'POLE3']",0.9586283511893411,0,0,5
171,Folate Metabolism WP176,0.30967106683852785,1.4202220923436586,1.6648477063239604,"['SERPINA3', 'GPX2', 'AHCY', 'RFK', 'APOA1']",0.9586283511893411,0,0,5
172,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.31147916470562054,1.2461693506920877,1.4535603806586528,"['JUN', 'TGFB1', 'CCND1', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'PTGS2', 'BBC3', 'GADD45G']",0.9586283511893411,0,0,10
173,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.31444285969820124,1.4948352188883423,1.7294539497707009,"['CCND1', 'FGF1', 'RUNX2', 'GLI2']",0.9586283511893411,0,0,4
174,BMP Signaling Pathway in Eyelid Development WP3927,0.31611640644555505,1.6384211235349588,1.886879098972296,"['JUN', 'NOTCH1', 'FGF10']",0.9586283511893411,0,0,3
175,miRNA targets in ECM and membrane receptors WP2911,0.31611640644555505,1.6384211235349588,1.886879098972296,"['COL5A1', 'LAMB2', 'FN1']",0.9586283511893411,0,0,3
176,Urea cycle and metabolism of amino groups WP497,0.31611640644555505,1.6384211235349588,1.886879098972296,"['CPS1', 'PYCR1', 'PYCR3']",0.9586283511893411,0,0,3
177,Aryl Hydrocarbon Receptor Netpath WP2586,0.3265646532741409,1.331469298245614,1.4900836815913854,"['HSP90AA1', 'CDKN1B', 'AIP', 'AHR', 'PTGS2', 'VEGFA']",0.9586283511893411,0,0,6
178,IL-6 signaling pathway WP364,0.3265646532741409,1.331469298245614,1.4900836815913854,"['HCK', 'PRKCD', 'GAB1', 'VIP', 'IL6ST', 'JUNB']",0.9586283511893411,0,0,6
179,Integrated Cancer Pathway WP1971,0.3265646532741409,1.331469298245614,1.4900836815913854,"['CDKN1B', 'CASP8', 'CHEK2', 'BAX', 'BACH1', 'BBC3']",0.9586283511893411,0,0,6
180,let-7 inhibition of ES cell reprogramming WP3299,0.32672352044280917,3.548979591836735,3.9700339694220914,['EGR1'],0.9586283511893411,0,0,1
181,Nanomaterial-induced inflammasome activation WP3890,0.32672352044280917,3.548979591836735,3.9700339694220914,['TLR4'],0.9586283511893411,0,0,1
182,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.32672352044280917,3.548979591836735,3.9700339694220914,['VEGFA'],0.9586283511893411,0,0,1
183,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.3439818288841436,1.4199766355140186,1.515351419546022,"['RAB3B', 'RAB3A', 'SH3TC2', 'RAB11A']",0.9836509202271526,0,0,4
184,TGF-beta Receptor Signaling WP560,0.34958768229076864,1.2910154173312067,1.3568583262092098,"['JUN', 'TGFB1', 'EGF', 'FST', 'LTBP1', 'RUNX2']",0.9836509202271526,0,0,6
185,Apoptosis Modulation by HSP70 WP384,0.35184987282876007,1.5212659494620966,1.5890394002351849,"['CASP7', 'CASP8', 'CYCS']",0.9836509202271526,0,0,3
186,Constitutive Androstane Receptor Pathway WP2875,0.35184987282876007,1.5212659494620966,1.5890394002351849,"['HSP90AA1', 'ABCB1', 'ABCC2']",0.9836509202271526,0,0,3
187,Nicotine Activity on Dopaminergic Neurons WP1602,0.35184987282876007,1.5212659494620966,1.5890394002351849,"['CHRNB2', 'DRD2', 'SLC18A2']",0.9836509202271526,0,0,3
188,Cysteine and methionine catabolism WP4504,0.3554424684461352,1.7746499416569428,1.8356834817137626,"['AHCY', 'GOT1']",0.9836509202271526,0,0,2
189,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.3554424684461352,1.7746499416569428,1.8356834817137626,"['HMGCS1', 'HMGCR']",0.9836509202271526,0,0,2
190,Neuroinflammation WP4919,0.3554424684461352,1.7746499416569428,1.8356834817137626,"['JUN', 'TLR4']",0.9836509202271526,0,0,2
191,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.3554424684461352,1.7746499416569428,1.8356834817137626,"['JUN', 'TLR4']",0.9836509202271526,0,0,2
192,Transcriptional cascade regulating adipogenesis WP4211,0.3554424684461352,1.7746499416569428,1.8356834817137626,"['CEBPB', 'DDIT3']",0.9836509202271526,0,0,2
193,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.3563954351291424,1.2058891799582188,1.2441332218150418,"['PSMD8', 'TUBB8', 'TUBA1C', 'TUBB6', 'CASP8', 'TUBB2A', 'HSPA5', 'UBE2L6', 'HSPA1B']",0.9836509202271526,0,0,9
194,Endochondral Ossification with Skeletal Dysplasias WP4808,0.360129339992255,1.242612638970158,1.2690703899013653,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'GLI3', 'RUNX2', 'VEGFA']",0.9836509202271526,0,0,7
195,Endochondral Ossification WP474,0.360129339992255,1.242612638970158,1.2690703899013653,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'GLI3', 'RUNX2', 'VEGFA']",0.9836509202271526,0,0,7
196,Prostaglandin Synthesis and Regulation WP98,0.36104041266764403,1.3148039916011862,1.3394767887431451,"['HSD11B1', 'EDN1', 'HPGD', 'ANXA2', 'PTGS2']",0.9836509202271526,0,0,5
197,Hematopoietic Stem Cell Differentiation WP2849,0.3735728354941507,1.3522474410324878,1.3314800107704654,"['NOTCH1', 'IL5', 'FOSB', 'RUNX1']",0.9999639263661667,0,0,4
198,Neural Crest Differentiation WP2064,0.3747494274373988,1.183460261667643,1.1615634891901392,"['NOTCH1', 'DLX5', 'NOTCH4', 'ZIC1', 'WNT8A', 'ASCL1', 'ETS1', 'GFAP', 'DLL3']",0.9999639263661667,0,0,9
199,PI3K-Akt signaling pathway WP4172,0.3760450704424374,1.0795979519404202,1.0558967549372469,"['CDKN1B', 'ITGB4', 'FGF1', 'THBS4', 'RELN', 'CCND1', 'PDGFD', 'PCK2', 'PDGFRB', 'HSP90AA1', 'ANGPT2', 'ANGPT1', 'LAMB3', 'EGF', 'LAMB2', 'LAMB4', 'FN1', 'PPP2R5B', 'VEGFC', 'EPOR', 'VEGFA', 'CREB3', 'CCNE2', 'LPAR6', 'IL7', 'COL6A6', 'SGK1', 'FGFR4', 'SGK2', 'TLR4', 'FGF10']",0.9999639263661667,0,0,31
200,Parkinson's disease pathway WP2371,0.38685256896202086,1.267742339484011,1.2039896275384245,"['CASP7', 'PINK1', 'CCNE2', 'CYCS', 'UBE2L6']",0.9999639263661667,0,0,5
201,One-carbon metabolism WP241,0.3873475891237775,1.4197314652656159,1.346519925690516,"['AHCY', 'CHDH', 'GLRX']",0.9999639263661667,0,0,3
202,Purinergic signaling WP4900,0.3873475891237775,1.4197314652656159,1.346519925690516,"['ADORA2A', 'LPAR6', 'P2RY14']",0.9999639263661667,0,0,3
203,Calcium Regulation in the Cardiac Cell WP536,0.387643072567588,1.107624020605753,1.0496623644177199,"['KCNJ5', 'PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'ATP1B1', 'RGS4', 'GJD2', 'RGS5', 'RGS2', 'PLN', 'PRKAR1A', 'CALM3', 'CALR', 'CASQ1', 'YWHAG']",0.9999639263661667,0,0,17
204,Alanine and aspartate metabolism WP106,0.4020406047109824,1.5773369635680021,1.4372728935524637,"['GOT1', 'GAD1']",0.9999639263661667,0,0,2
205,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.4020406047109824,1.5773369635680021,1.4372728935524637,"['CCND1', 'ROS1']",0.9999639263661667,0,0,2
206,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.4020406047109824,1.5773369635680021,1.4372728935524637,"['TGFB1', 'CCND1']",0.9999639263661667,0,0,2
207,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.4020406047109824,1.5773369635680021,1.4372728935524637,"['MAVS', 'TMEM173']",0.9999639263661667,0,0,2
208,RalA downstream regulated genes WP2290,0.4020406047109824,1.5773369635680021,1.4372728935524637,"['EXOC8', 'YBX3']",0.9999639263661667,0,0,2
209,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4020406047109824,1.5773369635680021,1.4372728935524637,"['PTTG1', 'MAD2L1']",0.9999639263661667,0,0,2
210,Oxysterols derived from cholesterol WP4545,0.40304724461405245,1.2906754460492778,1.172838703014141,"['INSIG1', 'ACOT2', 'DHCR7', 'ACOT6']",0.9999639263661667,0,0,4
211,White fat cell differentiation WP4149,0.40304724461405245,1.2906754460492778,1.172838703014141,"['CEBPB', 'DDIT3', 'EBF1', 'NR2F2']",0.9999639263661667,0,0,4
212,Circadian rhythm related genes WP3594,0.40532247635337826,1.084185510586202,0.9790978926921062,"['CHRNB2', 'EGR1', 'JUN', 'MAGEL2', 'EGR3', 'AHCY', 'HOMER1', 'AHR', 'HCRTR2', 'PER2', 'PPP1CC', 'HTR7', 'STAR', 'NFIL3', 'ADORA2A', 'CRH', 'ID3', 'ATF5', 'RPS27A', 'DRD2']",0.9999639263661667,0,0,20
213,Gene regulatory network modelling somitogenesis  WP2854,0.4099133768149587,2.3657920310981537,2.109835613574379,['NOTCH1'],0.9999639263661667,0,0,1
214,Macrophage markers WP4146,0.4099133768149587,2.3657920310981537,2.109835613574379,['CD74'],0.9999639263661667,0,0,1
215,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.4099133768149587,2.3657920310981537,2.109835613574379,['VEGFA'],0.9999639263661667,0,0,1
216,Vitamin B6-dependent and responsive disorders WP4228,0.4099133768149587,2.3657920310981537,2.109835613574379,['PNPO'],0.9999639263661667,0,0,1
217,ATM Signaling Pathway WP2516,0.41259850617227517,1.2239263185473306,1.083517857083803,"['JUN', 'CRADD', 'GADD45A', 'CHEK2', 'RAD9A']",0.9999639263661667,0,0,5
218,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.41259850617227517,1.2239263185473306,1.083517857083803,"['MAP1LC3A', 'MSTN', 'IGFBP5', 'TNFSF9', 'PLD1']",0.9999639263661667,0,0,5
219,Fas ligand pathway and stress induction of heat shock proteins WP314,0.41259850617227517,1.2239263185473306,1.083517857083803,"['CASP7', 'JUN', 'CASP8', 'CYCS', 'ACTG1']",0.9999639263661667,0,0,5
220,Nonalcoholic fatty liver disease WP4396,0.41384795565701515,1.0874865448143847,0.95944221363198,"['XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'UQCRB', 'NDUFB10', 'NDUFB11', 'UQCR10', 'COX7C', 'BBC3', 'CASP7', 'CASP8', 'DDIT3', 'LEPR', 'CYCS', 'BAX', 'CYC1']",0.9999639263661667,0,0,17
221,Kallmann's Syndrome WP5074,0.4223514641481236,1.3308887915936953,1.147116284323475,"['TMEM98', 'GNRH1', 'ASCL1']",0.9999639263661667,0,0,3
222,NAD+ biosynthetic pathways WP3645,0.4223514641481236,1.3308887915936953,1.147116284323475,"['NMNAT1', 'TDO2', 'ACMSD']",0.9999639263661667,0,0,3
223,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.4223514641481236,1.3308887915936953,1.147116284323475,"['EGR1', 'HTR7', 'RPS6KA5']",0.9999639263661667,0,0,3
224,Triacylglyceride synthesis WP325,0.4223514641481236,1.3308887915936953,1.147116284323475,"['MOGAT1', 'GPD1', 'AGPAT1']",0.9999639263661667,0,0,3
225,p53 transcriptional gene network WP4963,0.4237666766163278,1.155632969096575,0.9921944171900934,"['BTG2', 'NOTCH1', 'GADD45A', 'BAX', 'SLC7A11', 'BBC3', 'RPRM']",0.9999639263661667,0,0,7
226,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4322520450030203,1.234457537586347,1.0353968444459283,"['FYB1', 'RAB13', 'FOXO4', 'FERMT3']",0.9999639263661667,0,0,4
227,Oxidation by Cytochrome P450 WP43,0.4322520450030203,1.234457537586347,1.0353968444459283,"['CYB5R1', 'CYP26A1', 'CYP2C18', 'CYP3A7']",0.9999639263661667,0,0,4
228,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.4322520450030203,1.234457537586347,1.0353968444459283,"['ACTA2', 'CASP8', 'TGFB1', 'BAX']",0.9999639263661667,0,0,4
229,Ebola Virus Pathway on Host WP4217,0.4368391288196866,1.0857656039515042,0.8992205173060323,"['VPS18', 'GSN', 'CAV3', 'HLA-C', 'HLA-A', 'HLA-F', 'MERTK', 'ASGR1', 'ACTG1', 'HLA-E', 'HLA-DRA', 'TLR4', 'CLEC4G']",0.9999639263661667,0,0,13
230,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.44210848603491604,1.1510668563300142,0.9395007491472486,"['PPP1R15A', 'PPP1CC', 'XBP1', 'MAP1LC3A', 'HSPA5', 'DDIT3']",0.9999639263661667,0,0,6
231,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.44210848603491604,1.1510668563300142,0.9395007491472486,"['JUN', 'TGFB1', 'EGF', 'FST', 'LTBP1', 'RUNX2']",0.9999639263661667,0,0,6
232,Hedgehog Signaling Pathway Netpath WP47,0.446968861704295,1.4194865810968496,1.1430647743598832,"['GLI3', 'GLI2']",0.9999639263661667,0,0,2
233,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.446968861704295,1.4194865810968496,1.1430647743598832,"['TGFB1', 'TLR4']",0.9999639263661667,0,0,2
234,Monoamine Transport WP727,0.4566424188538522,1.2524981971772948,0.9817765330157847,"['TDO2', 'ADORA2A', 'IL1R1']",0.9999639263661667,0,0,3
235,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.46105028661192377,1.1829244548286604,0.9158770829802904,"['CREB3', 'STAR', 'CALM3', 'CAMK1G']",0.9999639263661667,0,0,4
236,The influence of laminopathies on Wnt signaling WP4844,0.46105028661192377,1.1829244548286604,0.9158770829802904,"['CEBPB', 'CCND1', 'TCF7', 'RUNX2']",0.9999639263661667,0,0,4
237,Nephrotic syndrome WP4758,0.4634846258375798,1.1447747968552628,0.8803112863760457,"['CUBN', 'MYO1E', 'ITGB4', 'LAMB2', 'GPC5']",0.9999639263661667,0,0,5
238,Cytosolic DNA-sensing pathway WP4655,0.4649538696621651,1.1206832871652816,0.8582384063287521,"['MAVS', 'CASP8', 'IL18', 'POLR2E', 'TMEM173', 'POLR2K']",0.9999639263661667,0,0,6
239,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.48282954875703915,1.774198250728863,1.291778823109292,['CYP2C18'],0.9999639263661667,0,0,1
240,EV release from cardiac cells and their functional effects WP3297,0.48282954875703915,1.774198250728863,1.291778823109292,['RGS16'],0.9999639263661667,0,0,1
241,FOXP3 in COVID-19 WP5063,0.48282954875703915,1.774198250728863,1.291778823109292,['IL6ST'],0.9999639263661667,0,0,1
242,FTO Obesity Variant Mechanism WP3407,0.48282954875703915,1.774198250728863,1.291778823109292,['PRDM16'],0.9999639263661667,0,0,1
243,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.48282954875703915,1.774198250728863,1.291778823109292,['ACOT2'],0.9999639263661667,0,0,1
244,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.48282954875703915,1.774198250728863,1.291778823109292,['ABCB1'],0.9999639263661667,0,0,1
245,miR-517 relationship with ARCN1 and USP1 WP3596,0.48282954875703915,1.774198250728863,1.291778823109292,['ARCN1'],0.9999639263661667,0,0,1
246,Mitochondrial fatty acid synthesis pathway WP4317,0.48282954875703915,1.774198250728863,1.291778823109292,['HSD17B12'],0.9999639263661667,0,0,1
247,Tgif disruption of Shh signaling WP3674,0.48282954875703915,1.774198250728863,1.291778823109292,['GLI3'],0.9999639263661667,0,0,1
248,The alternative pathway of fetal androgen synthesis WP4524,0.48282954875703915,1.774198250728863,1.291778823109292,['STAR'],0.9999639263661667,0,0,1
249,Vitamin D Metabolism WP1531,0.48282954875703915,1.774198250728863,1.291778823109292,['DHCR7'],0.9999639263661667,0,0,1
250,Glioblastoma signaling pathways WP2261,0.4842387877280047,1.0592990498853914,0.7681794457129582,"['PDGFRB', 'CDKN1B', 'PRKCH', 'CDKN2C', 'CCND1', 'CDKN2A', 'PRKCD', 'GAB1', 'SPRY2', 'FOXO4']",0.9999639263661667,0,0,10
251,Prion disease pathway WP3995,0.489321131097191,1.1355140186915889,0.8115930829088341,"['PRNP', 'HSPA5', 'RFX5', 'EBF1']",0.9999639263661667,0,0,4
252,Tumor suppressor activity of SMARCB1 WP4204,0.489321131097191,1.1355140186915889,0.8115930829088341,"['H3F3B', 'CDKN2A', 'GLI3', 'GLI2']",0.9999639263661667,0,0,4
253,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.48992864209067255,1.2903362681659065,0.9206491554928131,"['CCND1', 'TULP3']",0.9999639263661667,0,0,2
254,miRNAs involved in DNA damage response WP1545,0.48992864209067255,1.2903362681659065,0.9206491554928131,"['CDKN1B', 'CCND1']",0.9999639263661667,0,0,2
255,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.48992864209067255,1.2903362681659065,0.9206491554928131,"['LDHA', 'HLA-DRA']",0.9999639263661667,0,0,2
256,Pyrimidine metabolism and related diseases WP4225,0.48992864209067255,1.2903362681659065,0.9206491554928131,"['NT5C', 'CPS1']",0.9999639263661667,0,0,2
257,Type II diabetes mellitus WP1584,0.48992864209067255,1.2903362681659065,0.9206491554928131,"['KCNJ11', 'PRKCD']",0.9999639263661667,0,0,2
258,Fatty Acid Biosynthesis WP357,0.49003818586111375,1.182817668807161,0.8436706776447475,"['ACLY', 'ACSL5', 'ACACB']",0.9999639263661667,0,0,3
259,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.49003818586111375,1.182817668807161,0.8436706776447475,"['ANGPT2', 'LTBP1', 'RUNX2']",0.9999639263661667,0,0,3
260,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.49003818586111375,1.182817668807161,0.8436706776447475,"['BMP2', 'ASCL1', 'GLI2']",0.9999639263661667,0,0,3
261,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5072207983713234,1.0569326344882537,0.7174552477558024,"['JUN', 'CDKN1B', 'FN1', 'PFN4', 'WNT16', 'NEFH', 'PFN2']",0.9999639263661667,0,0,7
262,Modulators of TCR signaling and T cell activation WP5072,0.5098216667590656,1.0644736842105262,0.7171298401775963,"['MAP4K1', 'CDKN1B', 'NDUFB10', 'PTPN6', 'CD247', 'ZFP36L1']",0.9999639263661667,0,0,6
263,One-carbon metabolism and related pathways WP3940,0.5129692077471212,1.0752173990046578,0.7177500413740137,"['DMGDH', 'GPX2', 'CHDH', 'GAD1', 'PLD1']",0.9999639263661667,0,0,5
264,miRNA regulation of prostate cancer signaling pathways WP3981,0.51695958860886,1.0917505391804456,0.7203267134863548,"['PDGFRB', 'CDKN1B', 'CCND1', 'TCF7']",0.9999639263661667,0,0,4
265,Physiological and pathological hypertrophy of the heart WP1528,0.5223906269529013,1.1204719328970412,0.7275668454153456,"['EDN1', 'JUN', 'IL6ST']",0.9999639263661667,0,0,3
266,3q29 copy number variation syndrome WP4906,0.5274855824636692,1.0348278720499318,0.6619108280863761,"['CASP7', 'JUN', 'TGFB1', 'NCBP2', 'DYNLT3', 'SLC51A', 'DYNLL2']",0.9999639263661667,0,0,7
267,AGE/RAGE pathway WP2324,0.5274855824636692,1.0348278720499318,0.6619108280863761,"['LGALS3', 'MSR1', 'JUN', 'CASP8', 'PRKCD', 'CYCS', 'FOXO4']",0.9999639263661667,0,0,7
268,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5307205167570449,1.1827110073901206,0.7492707581801948,"['SYTL4', 'SYTL3']",0.9999639263661667,0,0,2
269,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5307205167570449,1.1827110073901206,0.7492707581801948,"['EGF', 'TLR4']",0.9999639263661667,0,0,2
270,Mammalian disorder of sexual development WP4842,0.5307205167570449,1.1827110073901206,0.7492707581801948,"['EMX2', 'FST']",0.9999639263661667,0,0,2
271,Riboflavin and CoQ disorders WP5037,0.5307205167570449,1.1827110073901206,0.7492707581801948,"['SLC52A2', 'RFK']",0.9999639263661667,0,0,2
272,Transcription co-factors SKI and SKIL protein partners WP4533,0.5307205167570449,1.1827110073901206,0.7492707581801948,"['SATB2', 'MERTK']",0.9999639263661667,0,0,2
273,Vitamin A and carotenoid metabolism WP716,0.5438760054009648,1.0512287988923503,0.6402340691139533,"['CYP26A1', 'ALDH1A3', 'RBP2', 'BCO1']",0.9999639263661667,0,0,4
274,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.5467401531403219,1.4192419825072886,0.8569122366972756,['RUNX2'],0.9999639263661667,0,0,1
275,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.5467401531403219,1.4192419825072886,0.8569122366972756,['CEBPB'],0.9999639263661667,0,0,1
276,Irinotecan pathway WP229,0.5467401531403219,1.4192419825072886,0.8569122366972756,['ABCC2'],0.9999639263661667,0,0,1
277,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5467401531403219,1.4192419825072886,0.8569122366972756,['AHCY'],0.9999639263661667,0,0,1
278,Methylation Pathways WP704,0.5467401531403219,1.4192419825072886,0.8569122366972756,['NNMT'],0.9999639263661667,0,0,1
279,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.5467401531403219,1.4192419825072886,0.8569122366972756,['STRADB'],0.9999639263661667,0,0,1
280,miRNA Biogenesis WP2338,0.5467401531403219,1.4192419825072886,0.8569122366972756,['RAN'],0.9999639263661667,0,0,1
281,Osteoblast Signaling WP322,0.5467401531403219,1.4192419825072886,0.8569122366972756,['PDGFRB'],0.9999639263661667,0,0,1
282,Small Ligand GPCRs WP247,0.5467401531403219,1.4192419825072886,0.8569122366972756,['S1PR3'],0.9999639263661667,0,0,1
283,Male infertility WP4673,0.5477098767921873,1.0005789909015717,0.6023581121939581,"['ABCB1', 'MSH5', 'DND1', 'DDX20', 'HLA-DRA', 'PEX10', 'AHR', 'HORMAD1', 'TEX15', 'ETV5', 'RAG1']",0.9999639263661667,0,0,11
284,Pathogenic Escherichia coli infection WP2272,0.5532139536899563,1.0136173767752714,0.6000720853528594,"['TUBB8', 'TUBA1C', 'TUBB6', 'TUBB2A', 'TLR4', 'ACTG1']",0.9999639263661667,0,0,6
285,Synaptic Vesicle Pathway WP2267,0.5532139536899563,1.0136173767752714,0.6000720853528594,"['RAB3A', 'SLC32A1', 'SYN3', 'CPLX1', 'SLC18A2', 'CPLX3']",0.9999639263661667,0,0,6
286,Cannabinoid receptor signaling WP3869,0.5535827734608915,1.0643607705779334,0.6294033474978856,"['ADORA2A', 'PRKAR1A', 'AHR']",0.9999639263661667,0,0,3
287,DNA Mismatch Repair WP531,0.5535827734608915,1.0643607705779334,0.6294033474978856,"['RPA3', 'POLE2', 'POLE3']",0.9999639263661667,0,0,3
288,Cell cycle WP179,0.559274781153339,0.9899279397314117,0.5752613492491169,"['TGFB1', 'CDKN1B', 'CDKN2C', 'CCND1', 'PTTG1', 'CCNE2', 'GADD45A', 'CDKN2A', 'CHEK2', 'YWHAG', 'GADD45G', 'SMC1B']",0.9999639263661667,0,0,12
289,IL-3 signaling pathway WP286,0.560461525944233,1.013609418051265,0.5868744618751223,"['HCK', 'JUN', 'TGFB1', 'IL5RA', 'PTPN6']",0.9999639263661667,0,0,5
290,Regulation of Microtubule Cytoskeleton WP2038,0.560461525944233,1.013609418051265,0.5868744618751223,"['SPRED1', 'PARD6A', 'CFL2', 'TESK2', 'EPHB2']",0.9999639263661667,0,0,5
291,ESC Pluripotency Pathways WP3931,0.5633201525339343,0.9878317680685994,0.5669237224714961,"['PDGFRB', 'JUN', 'EGF', 'GAB1', 'FGF1', 'IL6ST', 'BMPR1B', 'FGFR4', 'WNT16', 'FGF10', 'ERAS']",0.9999639263661667,0,0,11
292,Proteasome Degradation WP183,0.5669929618997109,0.9932709186658865,0.5635902510128135,"['PSMD8', 'H2AFZ', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB10', 'HLA-E']",0.9999639263661667,0,0,7
293,Androgen receptor signaling pathway WP138,0.5678724102227866,0.985329555816074,0.5575571196175853,"['JUN', 'CCND1', 'RNF6', 'BMF', 'CALR', 'FKBP4', 'ETV5', 'RUNX2', 'RAN', 'RAD9A']",0.9999639263661667,0,0,10
294,Pancreatic adenocarcinoma pathway WP4263,0.5678724102227866,0.985329555816074,0.5575571196175853,"['TGFB1', 'CCND1', 'CDKN2A', 'EGF', 'GADD45A', 'PRKCD', 'BAX', 'PLD1', 'VEGFA', 'GADD45G']",0.9999639263661667,0,0,10
295,PPAR-alpha pathway WP2878,0.5692243029105998,1.0916434790413787,0.6151200503523884,"['CCND1', 'APOA1']",0.9999639263661667,0,0,2
296,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5692243029105998,1.0916434790413787,0.6151200503523884,"['HMGCS1', 'HMGCR']",0.9999639263661667,0,0,2
297,Mitochondrial CIV Assembly WP4922,0.5699953598370942,1.0136014686248331,0.5697728123771089,"['COA3', 'COX14', 'COX7C', 'PET117']",0.9999639263661667,0,0,4
298,T-cell receptor (TCR) signaling pathway WP69,0.579069567556564,0.9785189372526851,0.5345968513117495,"['MAP4K1', 'VAV3', 'JUN', 'TGFB1', 'FYB1', 'PRKCD', 'PTK2B', 'CD247']",0.9999639263661667,0,0,8
299,Oxidative Stress WP408,0.583525745699235,1.013593528479693,0.5459890865512975,"['NOX3', 'NOX5', 'JUNB']",0.9999639263661667,0,0,3
300,Endoderm differentiation WP2853,0.5978994311217967,0.9604802798982188,0.49400642963773184,"['VAV3', 'DUSP4', 'DUSP5', 'DUSP2', 'NOTCH1', 'TGFB1', 'TCF7', 'SLC2A12', 'PBX3', 'WNT8A', 'DKK1', 'GLI2', 'TOX']",0.9999639263661667,0,0,13
301,Biomarkers for urea cycle disorders WP4583,0.6027568596232881,1.1826044703595724,0.5986833207730896,['GOT1'],0.9999639263661667,0,0,1
302,Dual hijack model of Vif in HIV infection WP3300,0.6027568596232881,1.1826044703595724,0.5986833207730896,['RUNX1'],0.9999639263661667,0,0,1
303,Glucuronidation WP698,0.6027568596232881,1.1826044703595724,0.5986833207730896,['PGM5'],0.9999639263661667,0,0,1
304,LTF danger signal response pathway WP4478,0.6027568596232881,1.1826044703595724,0.5986833207730896,['TLR4'],0.9999639263661667,0,0,1
305,Serotonin Transporter Activity WP1455,0.6027568596232881,1.1826044703595724,0.5986833207730896,['IL1R1'],0.9999639263661667,0,0,1
306,Sulfation Biotransformation Reaction WP692,0.6027568596232881,1.1826044703595724,0.5986833207730896,['SULT4A1'],0.9999639263661667,0,0,1
307,Vitamin B12 Disorders WP4271,0.6027568596232881,1.1826044703595724,0.5986833207730896,['CUBN'],0.9999639263661667,0,0,1
308,Glycosaminoglycan degradation WP4815,0.6053825469421524,1.0135855975996,0.5087132513707043,"['HYAL2', 'IDS']",0.9999639263661667,0,0,2
309,"GPCRs, Class B Secretin-like WP334",0.6053825469421524,1.0135855975996,0.5087132513707043,"['CALCR', 'ADGRG2']",0.9999639263661667,0,0,2
310,Methionine De Novo and Salvage Pathway WP3580,0.6053825469421524,1.0135855975996,0.5087132513707043,"['AHCY', 'CHDH']",0.9999639263661667,0,0,2
311,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6053825469421524,1.0135855975996,0.5087132513707043,"['TMEM173', 'NFKBIE']",0.9999639263661667,0,0,2
312,Transcription factor regulation in adipogenesis WP3599,0.6053825469421524,1.0135855975996,0.5087132513707043,"['CEBPB', 'PCK2']",0.9999639263661667,0,0,2
313,Eukaryotic Transcription Initiation WP405,0.6055080499641058,0.9586617593631036,0.480948545991143,"['TAF13', 'POLR2E', 'TAF7', 'POLR2I', 'POLR2K']",0.9999639263661667,0,0,5
314,Signal transduction through IL1R WP4496,0.6121556669286639,0.9674414902085655,0.47478997450377325,"['JUN', 'TGFB1', 'IL1R1']",0.9999639263661667,0,0,3
315,Sphingolipid pathway WP1422,0.6121556669286639,0.9674414902085655,0.47478997450377325,"['CERS4', 'SPHK1', 'SERINC1']",0.9999639263661667,0,0,3
316,Oxidative phosphorylation WP623,0.6147358473786061,0.9458089668615984,0.4601952888427803,"['NDUFA7', 'ATP6AP1', 'NDUFB10', 'ATP6AP2', 'ATP5MC3', 'ATP5MC1']",0.9999639263661667,0,0,6
317,Signaling of Hepatocyte Growth Factor Receptor WP313,0.619610788075054,0.9458722741433022,0.45275477849930623,"['MAP4K1', 'JUN', 'GAB1', 'PTK2B']",0.9999639263661667,0,0,4
318,Amino Acid metabolism WP3925,0.6310312330331675,0.9301647022689753,0.42824775450263186,"['ACLY', 'LDHA', 'PKM', 'TDO2', 'GOT1', 'CPS1', 'MARS2', 'PYCR1']",0.9999639263661667,0,0,8
319,Nucleotide metabolism WP404,0.6391868752159864,0.9459354336833917,0.42336136611817266,"['PRPS1', 'OAZ1']",0.9999639263661667,0,0,2
320,Endothelin Pathways WP2197,0.6394306565231818,0.9253026726566664,0.41377416368886816,"['ADCY10', 'EDN1', 'NPY1R']",0.9999639263661667,0,0,3
321,Endometrial cancer WP4155,0.6409972269746267,0.9193918904275838,0.4088812916501343,"['CCND1', 'EGF', 'GADD45A', 'TCF7', 'BAX', 'FGF1', 'GADD45G']",0.9999639263661667,0,0,7
322,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6409972269746267,0.9193918904275838,0.4088812916501343,"['EGR1', 'JUN', 'CDKN1B', 'PAX8', 'APEX1', 'PLD1', 'TSHR']",0.9999639263661667,0,0,7
323,ATR Signaling WP3875,0.6518541808546621,1.0135776759683466,0.43374474556215376,['RAD9A'],0.9999639263661667,0,0,1
324,Canonical NF-KB pathway WP4562,0.6518541808546621,1.0135776759683466,0.43374474556215376,['NFKBIE'],0.9999639263661667,0,0,1
325,Leptin and adiponectin WP3934,0.6518541808546621,1.0135776759683466,0.43374474556215376,['LEPR'],0.9999639263661667,0,0,1
326,Mitochondrial CII Assembly WP4920,0.6518541808546621,1.0135776759683466,0.43374474556215376,['SDHAF1'],0.9999639263661667,0,0,1
327,Nephrogenesis WP5052,0.6518541808546621,1.0135776759683466,0.43374474556215376,['MEIS1'],0.9999639263661667,0,0,1
328,NLR Proteins WP288,0.6518541808546621,1.0135776759683466,0.43374474556215376,['EPHB2'],0.9999639263661667,0,0,1
329,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.6518541808546621,1.0135776759683466,0.43374474556215376,['TGFB1'],0.9999639263661667,0,0,1
330,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6538081795785357,0.9117499372332413,0.38744017984582396,"['PDGFRB', 'SHC4', 'SHC3', 'CCND1', 'EGF', 'PDGFD', 'GAB1', 'BAX', 'VEGFA']",0.9999639263661667,0,0,9
331,Non-small cell lung cancer WP4255,0.6636236206709258,0.900486970744582,0.36923579144714824,"['CASP8', 'CCND1', 'CDKN2A', 'EGF', 'GADD45A', 'CYCS', 'BAX', 'GADD45G']",0.9999639263661667,0,0,8
332,TGF-beta Signaling Pathway WP366,0.6639839843867067,0.9125538508049278,0.37368829210423116,"['MAP4K1', 'JUN', 'TGFB1', 'CITED1', 'ITGB4', 'FN1', 'ETS1', 'RUNX2', 'PARD6A', 'CCND1', 'STRAP', 'FOSB', 'JUNB']",0.9999639263661667,0,0,13
333,IL17 signaling pathway WP2112,0.6653279599748004,0.8866754232340922,0.36129823389206095,"['CEBPB', 'TRAF3IP2', 'IL17RE']",0.9999639263661667,0,0,3
334,Notch Signaling WP268,0.665464061959186,0.8866092289719626,0.36108991180964983,"['KCNJ5', 'NOTCH1', 'NOTCH4', 'DLL3']",0.9999639263661667,0,0,4
335,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6706667563650528,0.8867415402567095,0.35423808443357685,"['HPGD', 'PTGS2']",0.9999639263661667,0,0,2
336,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6706667563650528,0.8867415402567095,0.35423808443357685,"['PTGES2', 'PTGS2']",0.9999639263661667,0,0,2
337,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6706667563650528,0.8867415402567095,0.35423808443357685,"['MAVS', 'TLR4']",0.9999639263661667,0,0,2
338,DNA damage response (only ATM dependent) WP710,0.6740012687270445,0.8975024856426314,0.35408562954821626,"['JUN', 'TGFB1', 'CDKN1B', 'CCND1', 'CDKN2A', 'TCF7', 'BAX', 'WNT16', 'PCK2', 'BBC3']",0.9999639263661667,0,0,10
339,Melanoma WP4685,0.6751008435730692,0.8864101813926273,0.3482645339052426,"['CCND1', 'CDKN2A', 'GADD45A', 'BAX', 'CALM3', 'ETS1', 'GADD45G']",0.9999639263661667,0,0,7
340,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6821781022109101,0.9211538461538461,0.3523086528330785,"['CDKN1B', 'EPAS1', 'ITGB4', 'HIF3A', 'FGF1', 'THBS4', 'RELN', 'PDGFD', 'PELO', 'PDGFRB', 'HSP90AA1', 'ANGPT2', 'ANGPT1', 'LAMB3', 'EGF', 'LAMB2', 'FN1', 'PPP2R5B', 'VEGFC', 'EPOR', 'VEGFA', 'CREB3', 'COL5A1', 'LPAR6', 'FGFR4', 'FGF10']",0.9999639263661667,0,0,26
341,Integrated breast cancer pathway WP1984,0.6865811355230873,0.9010402654470451,0.33881895811318496,"['PLK3', 'JUN', 'GADD45A', 'AHR', 'HMGCR', 'JAKMIP1', 'BACH1', 'RASGRP3', 'FOSL2', 'VEGFA', 'CASP8', 'CCND1', 'CHEK2', 'BAX', 'FAU']",0.9999639263661667,0,0,15
342,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6869212250681723,0.8596714811668082,0.3228372957273672,"['MAP4K1', 'ACTA2', 'ITGB4', 'ACTG1']",0.9999639263661667,0,0,4
343,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6869212250681723,0.8596714811668082,0.3228372957273672,"['MAVS', 'CASP8', 'TGFB1', 'CXCL17']",0.9999639263661667,0,0,4
344,Hepatitis B infection WP4666,0.6886544510205093,0.89468613355073,0.3337319352348422,"['JUN', 'TICAM2', 'TGFB1', 'EGR3', 'ATP6AP1', 'SLC10A1', 'CREB3', 'MAVS', 'CASP8', 'CYCS', 'PTK2B', 'BAX', 'TLR4']",0.9999639263661667,0,0,13
345,GABA receptor Signaling WP4159,0.6898412570256752,0.851138353765324,0.3160223682810024,"['SLC32A1', 'GAD1', 'GABRD']",0.9999639263661667,0,0,3
346,Neural Crest Cell Migration during Development WP4564,0.6898412570256752,0.851138353765324,0.3160223682810024,"['JUN', 'EPHB2', 'EPHB3']",0.9999639263661667,0,0,3
347,Gastrin signaling pathway WP4659,0.6921310519279668,0.8861436950146627,0.3260831213536464,"['EGR1', 'JUN', 'BMP2', 'PRKCH', 'CDKN1B', 'CCND1', 'ANXA2', 'CDKN2A', 'PRKCD', 'PTGS2', 'VEGFA']",0.9999639263661667,0,0,11
348,Biotin Metabolism (including IEMs) WP5031,0.6948863861845229,0.8868075801749271,0.3228040958001889,['ACACB'],0.9999639263661667,0,0,1
349,Estrogen Receptor Pathway WP2881,0.6948863861845229,0.8868075801749271,0.3228040958001889,['JUN'],0.9999639263661667,0,0,1
350,Purine metabolism WP4792,0.6948863861845229,0.8868075801749271,0.3228040958001889,['PRPS1'],0.9999639263661667,0,0,1
351,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6998802894752274,0.8345116342919898,0.2977921166185012,"['H3F3B', 'H2AFZ']",0.9999639263661667,0,0,2
352,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6998802894752274,0.8345116342919898,0.2977921166185012,"['SPHK1', 'B3GALT1']",0.9999639263661667,0,0,2
353,Melatonin metabolism and effects WP3298,0.7129781701176865,0.8183349050249226,0.276846361222474,"['PER2', 'EDN1', 'APOE']",0.9999639263661667,0,0,3
354,Head and Neck Squamous Cell Carcinoma WP4674,0.7222926581154042,0.8411302079717548,0.2736405827688856,"['CASP8', 'NOTCH1', 'CCND1', 'CDKN2A', 'GAB1', 'FAT1', 'VEGFA']",0.9999639263661667,0,0,7
355,MECP2 and Associated Rett Syndrome WP3584,0.7222926581154042,0.8411302079717548,0.2736405827688856,"['GABRR2', 'DLX5', 'SST', 'GAD1', 'OPRK1', 'SGK1', 'FKBP5']",0.9999639263661667,0,0,7
356,15q13.3 copy number variation syndrome WP4942,0.7326023306953087,0.7882086167800454,0.24525288240520543,['CHRFAM7A'],0.9999639263661667,0,0,1
357,Cancer immunotherapy by CTLA4 blockade WP4582,0.7326023306953087,0.7882086167800454,0.24525288240520543,['PTPN6'],0.9999639263661667,0,0,1
358,Dopamine metabolism WP2436,0.7326023306953087,0.7882086167800454,0.24525288240520543,['TYR'],0.9999639263661667,0,0,1
359,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.7326023306953087,0.7882086167800454,0.24525288240520543,['MAFF'],0.9999639263661667,0,0,1
360,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.7326023306953087,0.7882086167800454,0.24525288240520543,['JUN'],0.9999639263661667,0,0,1
361,Nanoparticle triggered regulated necrosis WP2513,0.7326023306953087,0.7882086167800454,0.24525288240520543,['CASP8'],0.9999639263661667,0,0,1
362,TCA cycle in senescence WP5050,0.7326023306953087,0.7882086167800454,0.24525288240520543,['GOT1'],0.9999639263661667,0,0,1
363,BDNF-TrkB Signaling WP3676,0.7347579873558597,0.7879613413764027,0.24286079794732368,"['TRPC3', 'HOMER1', 'GAB1']",0.9999639263661667,0,0,3
364,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7347579873558597,0.7879613413764027,0.24286079794732368,"['PRKCH', 'STAR', 'PRKCD']",0.9999639263661667,0,0,3
365,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7377716820312177,0.8180161943319838,0.24877580175711142,"['CASP7', 'ANGPT2', 'ANGPT1', 'FN1', 'BAX', 'ANGPTL1']",0.9999639263661667,0,0,6
366,Glycerolipids and Glycerophospholipids WP4722,0.751840182277611,0.7465454768777252,0.21293828707318108,"['PLD1', 'CDIPT']",0.9999639263661667,0,0,2
367,Toll-like Receptor Signaling related to MyD88 WP3858,0.751840182277611,0.7465454768777252,0.21293828707318108,"['TICAM2', 'TLR4']",0.9999639263661667,0,0,2
368,Neural Crest Cell Migration in Cancer WP4565,0.7552096026464382,0.7597573179884913,0.21330942574673206,"['JUN', 'EPHB2', 'EPHB3']",0.9999639263661667,0,0,3
369,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7563944638241954,0.787713487888824,0.21992350996850318,"['JUN', 'PRKCH', 'PRKCD', 'ETS1', 'TLR4']",0.9999639263661667,0,0,5
370,Ganglio Sphingolipid Metabolism WP1423,0.7656584563087399,0.70932944606414,0.18940450189866803,['B3GALT1'],0.9999639263661667,0,0,1
371,Glutathione metabolism WP100,0.7656584563087399,0.70932944606414,0.18940450189866803,['GPX2'],0.9999639263661667,0,0,1
372,Leptin Insulin Overlap WP3935,0.7656584563087399,0.70932944606414,0.18940450189866803,['LEPR'],0.9999639263661667,0,0,1
373,"NAD metabolism, sirtuins and aging WP3630",0.7656584563087399,0.70932944606414,0.18940450189866803,['ROS1'],0.9999639263661667,0,0,1
374,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.7656584563087399,0.70932944606414,0.18940450189866803,['IL6ST'],0.9999639263661667,0,0,1
375,Serotonin and anxiety-related events WP3944,0.7656584563087399,0.70932944606414,0.18940450189866803,['CRH'],0.9999639263661667,0,0,1
376,Notch Signaling Pathway Netpath WP61,0.7717921203668613,0.7705257540721164,0.19959702165837406,"['NOTCH1', 'CCND1', 'HEY1', 'NOTCH4', 'DLL3']",0.9999639263661667,0,0,5
377,22q11.2 copy number variation syndrome WP4657,0.7745535538256613,0.8072790371738114,0.20623434468339877,"['SLC7A4', 'ACTA2', 'CLDN5', 'CYP26A1', 'RELN', 'SERPIND1', 'DRD2', 'RAN', 'FGF10']",0.9999639263661667,0,0,9
378,1q21.1 copy number variation syndrome WP4905,0.7747851049226746,0.7091598599766628,0.18095601798516994,"['FMO5', 'TJP3']",0.9999639263661667,0,0,2
379,Estrogen signaling pathway WP712,0.7747851049226746,0.7091598599766628,0.18095601798516994,"['JUN', 'GPER1']",0.9999639263661667,0,0,2
380,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7747851049226746,0.7091598599766628,0.18095601798516994,"['CEBPB', 'CCND1']",0.9999639263661667,0,0,2
381,MTHFR deficiency WP4288,0.7747851049226746,0.7091598599766628,0.18095601798516994,"['CHDH', 'CYCS']",0.9999639263661667,0,0,2
382,SARS-CoV-2 mitochondrial interactions WP5038,0.7747851049226746,0.7091598599766628,0.18095601798516994,"['MAVS', 'TMEM173']",0.9999639263661667,0,0,2
383,Signal Transduction of S1P Receptor WP26,0.7747851049226746,0.7091598599766628,0.18095601798516994,"['SPHK1', 'S1PR3']",0.9999639263661667,0,0,2
384,Sphingolipid Metabolism (general overview) WP4725,0.7747851049226746,0.7091598599766628,0.18095601798516994,"['CERS4', 'SPHK1']",0.9999639263661667,0,0,2
385,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.7747851049226746,0.7091598599766628,0.18095601798516994,"['CCND1', 'DKK1']",0.9999639263661667,0,0,2
386,B Cell Receptor Signaling Pathway WP23,0.7755774224506718,0.7984958933931458,0.20293570777549658,"['MAP4K1', 'JUN', 'TEC', 'PRKCD', 'GAB1', 'PTPN6', 'ETS1', 'RASGRP3']",0.9999639263661667,0,0,8
387,p38 MAPK Signaling Pathway WP400,0.7922809693325533,0.708990075890251,0.16508067557084768,"['RPS6KA5', 'DDIT3', 'HMGN1']",0.9999639263661667,0,0,3
388,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7922809693325533,0.708990075890251,0.16508067557084768,"['CASP7', 'JUN', 'CASP8']",0.9999639263661667,0,0,3
389,Type 2 papillary renal cell carcinoma WP4241,0.7922809693325533,0.708990075890251,0.16508067557084768,"['TGFB1', 'EPAS1', 'VEGFA']",0.9999639263661667,0,0,3
390,Biomarkers for pyrimidine metabolism disorders WP4584,0.7946301901296529,0.6447919427511264,0.1482237673433883,['NT5C'],0.9999639263661667,0,0,1
391,Cell Differentiation - Index expanded WP2023,0.7946301901296529,0.6447919427511264,0.1482237673433883,['RUNX2'],0.9999639263661667,0,0,1
392,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7946301901296529,0.6447919427511264,0.1482237673433883,['CCK'],0.9999639263661667,0,0,1
393,FOXA2 pathway WP5066,0.7946301901296529,0.6447919427511264,0.1482237673433883,['ABCC2'],0.9999639263661667,0,0,1
394,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.7946301901296529,0.6447919427511264,0.1482237673433883,['SFRP4'],0.9999639263661667,0,0,1
395,16p11.2 distal deletion syndrome WP4950,0.7958519602677829,0.6753347780185587,0.15420735466054222,"['C3', 'PLN']",0.9999639263661667,0,0,2
396,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7958519602677829,0.6753347780185587,0.15420735466054222,"['TICAM2', 'TLR4']",0.9999639263661667,0,0,2
397,Sphingolipid Metabolism (integrated pathway) WP4726,0.7958519602677829,0.6753347780185587,0.15420735466054222,"['CERS4', 'SPHK1']",0.9999639263661667,0,0,2
398,Pathways Regulating Hippo Signaling WP4540,0.7988210137173563,0.7764909691700619,0.17441413673086914,"['PDGFRB', 'PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'TCF7', 'FGFR4', 'CDH18']",0.9999639263661667,0,0,8
399,Alzheimer's disease WP2059,0.8019806490574367,0.7631093306927128,0.1683959463113522,"['CASP7', 'CASP8', 'PPP3R2', 'CYCS', 'CALM3', 'APOE', 'CDK5R1']",0.9999639263661667,0,0,7
400,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8019806490574367,0.7631093306927128,0.1683959463113522,"['MC4R', 'CREB3', 'NOTCH1', 'PAX8', 'DIO1', 'PRDM16', 'TSHR']",0.9999639263661667,0,0,7
401,MAPK Signaling Pathway WP382,0.8051943825914144,0.8416988416988417,0.18237220247398886,"['MAP4K1', 'DUSP4', 'PDGFRB', 'JUN', 'DUSP2', 'TGFB1', 'IL1R1', 'GADD45A', 'DUSP1', 'EGF', 'PRKCD', 'FGF1', 'DUSP7', 'RASGRP3', 'NR4A1', 'RPS6KA5', 'PPP3R2', 'DUSP10', 'DDIT3', 'FGFR4', 'HSPA1B', 'FGF10']",0.9999639263661667,0,0,22
402,DNA Replication WP466,0.808990960052522,0.6860629342974973,0.14542306986831893,"['RPA3', 'POLE2', 'GMNN']",0.9999639263661667,0,0,3
403,IL-5 signaling pathway WP127,0.808990960052522,0.6860629342974973,0.14542306986831893,"['SPRED1', 'JUN', 'IL5RA']",0.9999639263661667,0,0,3
404,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8097896465262094,0.708820093457944,0.14954740250944856,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'PIM2']",0.9999639263661667,0,0,4
405,Ethanol effects on histone modifications WP3996,0.8151543096599736,0.6445847035111912,0.13173883369176154,"['ALDH1A3', 'AHCY']",0.9999639263661667,0,0,2
406,Fatty acid transporters WP5061,0.8200219380134932,0.5910106899902818,0.11727081472798503,['ACSL5'],0.9999639263661667,0,0,1
407,Omega-3/Omega-6 FA synthesis WP4723,0.8200219380134932,0.5910106899902818,0.11727081472798503,['ACOT2'],0.9999639263661667,0,0,1
408,Omega-9 FA synthesis WP4724,0.8200219380134932,0.5910106899902818,0.11727081472798503,['ACOT2'],0.9999639263661667,0,0,1
409,Netrin-UNC5B signaling pathway WP4747,0.82455053045971,0.6645687390542907,0.12820650952467313,"['JUN', 'ITGB4', 'PTK2B']",0.9999639263661667,0,0,3
410,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8328063314768297,0.6165085485262036,0.11279280305655377,"['TGFB1', 'PROM1']",0.9999639263661667,0,0,2
411,Glycosylation and related congenital defects WP4521,0.8328063314768297,0.6165085485262036,0.11279280305655377,"['MPI', 'DOLK']",0.9999639263661667,0,0,2
412,Glycogen Synthesis and Degradation WP500,0.8390129093304822,0.6443772223106724,0.11310700935126665,"['PHKG1', 'PPP2R5B', 'CALM3']",0.9999639263661667,0,0,3
413,NAD+ metabolism WP3644,0.8422758455627246,0.545503476115721,0.09363442292767228,['NMNAT1'],0.9999639263661667,0,0,1
414,Serotonin and anxiety WP3947,0.8422758455627246,0.545503476115721,0.09363442292767228,['CRH'],0.9999639263661667,0,0,1
415,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8479699725510088,0.7561540870654557,0.12469741098605125,"['CLDN5', 'CLDN20', 'NOTCH1', 'TGFB1', 'NOTCH4', 'EIF5A2', 'FN1', 'WNT8A', 'STRAP', 'WNT16', 'DLL3']",0.9999639263661667,0,0,11
416,PPAR signaling pathway WP3942,0.8488391710752727,0.6592045207563573,0.10803409147692156,"['APOA1', 'ACSL5', 'ANGPTL4', 'PCK2']",0.9999639263661667,0,0,4
417,Glycerophospholipid Biosynthetic Pathway WP2533,0.8489209368824652,0.5907720731232984,0.09676209823524576,"['GPD1', 'CDIPT']",0.9999639263661667,0,0,2
418,Lipid Metabolism Pathway WP3965,0.8489209368824652,0.5907720731232984,0.09676209823524576,"['ACLY', 'PRKAR1A']",0.9999639263661667,0,0,2
419,Copper homeostasis WP3286,0.8524327363572601,0.6253734418460904,0.09984773319601448,"['PRNP', 'JUN', 'CCND1']",0.9999639263661667,0,0,3
420,Pyrimidine metabolism WP4022,0.8539678440364852,0.708308952603862,0.1118148831883115,"['NT5C', 'POLE2', 'POLE3', 'POLR2E', 'CMPK2', 'POLR2I', 'POLR2K']",0.9999639263661667,0,0,7
421,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.8576604825329098,0.7171612367711143,0.11011793190336013,"['NDUFA7', 'UQCRB', 'NDUFB10', 'ATP5MC3', 'UQCR10', 'SLC25A5', 'COX7C', 'ATP5MC1']",0.9999639263661667,0,0,8
422,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8590906098813356,0.7604567535171283,0.11549884060601474,"['SHC4', 'VAV3', 'EGR1', 'LINGO1', 'JUN', 'RAB3A', 'SHC3', 'PRKCD', 'ACACB', 'BMP2', 'RPS6KA5', 'PTK2B', 'CDK5R1']",0.9999639263661667,0,0,13
423,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8593780726636133,0.6683722417652702,0.10128935541455118,"['SGCD', 'ITGB4', 'TCF7', 'SGCG', 'ACTG1']",0.9999639263661667,0,0,5
424,Rett syndrome causing genes WP4312,0.8602525064079862,0.6441694987255735,0.09696639707677437,"['CECR2', 'SATB2', 'IMPDH2', 'GABRD']",0.9999639263661667,0,0,4
425,Canonical and non-canonical TGF-B signaling WP3874,0.8617794792309353,0.5064972927946689,0.07534444321636538,['TGFB1'],0.9999639263661667,0,0,1
426,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.8617794792309353,0.5064972927946689,0.07534444321636538,['GADD45G'],0.9999639263661667,0,0,1
427,MAPK pathway in congenital thyroid cancer WP4928,0.8617794792309353,0.5064972927946689,0.07534444321636538,['JUN'],0.9999639263661667,0,0,1
428,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.8617794792309353,0.5064972927946689,0.07534444321636538,['JUN'],0.9999639263661667,0,0,1
429,SARS coronavirus and innate immunity WP4912,0.8617794792309353,0.5064972927946689,0.07534444321636538,['MAVS'],0.9999639263661667,0,0,1
430,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.8617794792309353,0.5064972927946689,0.07534444321636538,['ACLY'],0.9999639263661667,0,0,1
431,Intraflagellar transport proteins binding to dynein WP4532,0.8636083407284241,0.5670945157526255,0.08315642734634644,"['DYNLT3', 'DYNLL2']",0.9999639263661667,0,0,2
432,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8636083407284241,0.5670945157526255,0.08315642734634644,"['CDKN1B', 'FOXO4']",0.9999639263661667,0,0,2
433,Interleukin-11 Signaling Pathway WP2332,0.864865273555012,0.6074555916937703,0.0881913366415337,"['TGFB1', 'IL6ST', 'RUNX2']",0.9999639263661667,0,0,3
434,Pathways affected in adenoid cystic carcinoma WP3651,0.8692451761848276,0.6559408619607334,0.09191703070884398,"['NOTCH1', 'MYCBP', 'CHEK2', 'FGFR4', 'FOXP2']",0.9999639263661667,0,0,5
435,TNF-alpha signaling pathway WP231,0.8714030622840685,0.688519927182888,0.09477521626742091,"['CASP7', 'HSP90AA1', 'JUN', 'CASP8', 'RFK', 'BAX', 'NFKBIE']",0.9999639263661667,0,0,7
436,Hippo-Merlin Signaling Dysregulation WP4541,0.8738827980594626,0.6993379015236939,0.09427705061356179,"['PDGFRB', 'PPP1CC', 'LIN28B', 'CCND1', 'PRKAR1A', 'ITGB4', 'FGFR4', 'CDH18']",0.9999639263661667,0,0,8
437,Common Pathways Underlying Drug Addiction WP2636,0.8763657438197031,0.5905331776610235,0.07793370244312056,"['PPP1CC', 'DRD2', 'ACTG1']",0.9999639263661667,0,0,3
438,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8769750051908757,0.5452383089489273,0.0715771335490903,"['JUN', 'MAVS']",0.9999639263661667,0,0,2
439,Globo Sphingolipid Metabolism WP1424,0.8788725602337742,0.4726919339164237,0.061031796059952965,['FUT2'],0.9999639263661667,0,0,1
440,Wnt signaling pathway and pluripotency WP399,0.8794548536507978,0.679032038282421,0.08722373497811069,"['JUN', 'PRKCH', 'CCND1', 'PRKCD', 'TCF7', 'PPM1J', 'WNT16']",0.9999639263661667,0,0,7
441,Insulin Signaling WP481,0.8828041634245238,0.7447584884655822,0.09283555202819223,"['MAP4K1', 'EGR1', 'XBP1', 'JUN', 'PRKCH', 'SHC3', 'RRAD', 'PRKCD', 'GAB1', 'RPS6KA5', 'RHOJ', 'SGK1', 'SGK2', 'ARF6']",0.9999639263661667,0,0,14
442,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.889122884657639,0.5250010804269848,0.06169803512782151,"['PPP3R2', 'SUPT4H1']",0.9999639263661667,0,0,2
443,Nuclear receptors WP170,0.889122884657639,0.5250010804269848,0.06169803512782151,"['NR4A1', 'NR2F2']",0.9999639263661667,0,0,2
444,PDGFR-beta pathway WP3972,0.889122884657639,0.5250010804269848,0.06169803512782151,"['PDGFRB', 'JUN']",0.9999639263661667,0,0,2
445,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8901639706072959,0.6029031616623584,0.07014753964106049,"['CDKN2A', 'CHEK2', 'BAX', 'RAD9A']",0.9999639263661667,0,0,4
446,Ebstein-Barr virus LMP1 signaling WP262,0.893852868149755,0.4431122448979592,0.049723439263976724,['HSP90AA1'],0.9999639263661667,0,0,1
447,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.893852868149755,0.4431122448979592,0.049723439263976724,['EIF3I'],0.9999639263661667,0,0,1
448,Proteoglycan biosynthesis WP4784,0.893852868149755,0.4431122448979592,0.049723439263976724,['B4GALT7'],0.9999639263661667,0,0,1
449,Retinoblastoma gene in cancer WP2446,0.8941588194566287,0.6437533227006911,0.07201788750630149,"['CDKN1B', 'CCND1', 'CCNE2', 'H2AFZ', 'RPA3', 'POLE2']",0.9999639263661667,0,0,6
450,ATM Signaling Network in Development and Disease  WP3878,0.8967879927666053,0.5593603097059637,0.06093436075056358,"['CHEK2', 'HMGN1', 'CDK5R1']",0.9999639263661667,0,0,3
451,DNA IR-damage and cellular response via ATR WP4016,0.9013920971217944,0.6340926944226237,0.06582829255405574,"['SEM1', 'FEN1', 'BRIP1', 'POLN', 'CHEK2', 'RAD9A']",0.9999639263661667,0,0,6
452,Hippo-Yap signaling pathway WP4537,0.9069814158373145,0.41701251929343164,0.04071431623234123,['MAP4K1'],0.9999639263661667,0,0,1
453,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9069814158373145,0.41701251929343164,0.04071431623234123,['MAP1LC3A'],0.9999639263661667,0,0,1
454,miRNAs involvement in the immune response in sepsis WP4329,0.9069814158373145,0.41701251929343164,0.04071431623234123,['TLR4'],0.9999639263661667,0,0,1
455,Purine metabolism and related disorders WP4224,0.9069814158373145,0.41701251929343164,0.04071431623234123,['PRPS1'],0.9999639263661667,0,0,1
456,Vitamin D in inflammatory diseases WP4482,0.9069814158373145,0.41701251929343164,0.04071431623234123,['DUSP1'],0.9999639263661667,0,0,1
457,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9102031790061371,0.6001050035166272,0.05646233796708324,"['ACLY', 'SQLE', 'HMGCS1', 'INSIG1', 'HMGCR']",0.9999639263661667,0,0,5
458,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9141220802092359,0.5313047285464098,0.04770646229966725,"['ADCY10', 'TGFB1', 'BANF1']",0.9999639263661667,0,0,3
459,Mesodermal commitment pathway WP2857,0.9143013467957211,0.6633897188049209,0.059436442175852,"['VAV3', 'MEIS1', 'CCND1', 'PRKAR1A', 'SLC2A12', 'PBX3', 'RPL38', 'TOX', 'DKK1']",0.9999639263661667,0,0,9
460,Regulation of Actin Cytoskeleton WP51,0.916848242044116,0.6825693265421618,0.05925610552809588,"['PDGFRB', 'DIAPH3', 'GSN', 'EGF', 'CFL2', 'CHRM5', 'FN1', 'FGF1', 'FGFR4', 'ACTG1', 'FGF10']",0.9999639263661667,0,0,11
461,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9184869873907895,0.3938127632005183,0.03348493113183896,['SGK1'],0.9999639263661667,0,0,1
462,Immune response to tuberculosis WP4197,0.9184869873907895,0.3938127632005183,0.03348493113183896,['IFIT3'],0.9999639263661667,0,0,1
463,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.9184869873907895,0.3938127632005183,0.03348493113183896,['HTR2B'],0.9999639263661667,0,0,1
464,Fatty acid beta-oxidation WP143,0.9191963300587388,0.4723842862699339,0.03980099548623819,"['TPI1', 'ACSL5']",0.9999639263661667,0,0,2
465,IL-2 signaling pathway WP49,0.9191963300587388,0.4723842862699339,0.03980099548623819,"['JUN', 'PTK2B']",0.9999639263661667,0,0,2
466,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9191963300587388,0.4723842862699339,0.03980099548623819,"['HCK', 'TEC']",0.9999639263661667,0,0,2
467,ErbB signaling pathway WP673,0.9193868278267633,0.6271488989786017,0.052710813002097644,"['SHC4', 'JUN', 'CDKN1B', 'SHC3', 'CCND1', 'EGF', 'GAB1']",0.9999639263661667,0,0,7
468,IL-4 signaling pathway WP395,0.9217561335506573,0.5183033616675922,0.04222855266671129,"['CEBPB', 'NFIL3', 'PTPN6']",0.9999639263661667,0,0,3
469,Nucleotide Excision Repair WP4753,0.9217561335506573,0.5183033616675922,0.04222855266671129,"['RPA3', 'POLE2', 'POLE3']",0.9999639263661667,0,0,3
470,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9217561335506573,0.5183033616675922,0.04222855266671129,"['JUN', 'IL5', 'PTPN6']",0.9999639263661667,0,0,3
471,Amyotrophic lateral sclerosis (ALS) WP2447,0.9273843844922336,0.45710844280498364,0.034460100508251656,"['BAX', 'NEFH']",0.9999639263661667,0,0,2
472,Disruption of postsynaptic signaling by CNV WP4875,0.9273843844922336,0.45710844280498364,0.034460100508251656,"['HOMER1', 'YWHAG']",0.9999639263661667,0,0,2
473,Target Of Rapamycin (TOR) Signaling WP1471,0.9273843844922336,0.45710844280498364,0.034460100508251656,"['RRAGA', 'HMGCR']",0.9999639263661667,0,0,2
474,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9285701151203776,0.3730550866963327,0.02764688365817239,['H3F3B'],0.9999639263661667,0,0,1
475,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.9285701151203776,0.3730550866963327,0.02764688365817239,['GOT1'],0.9999639263661667,0,0,1
476,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.9285701151203776,0.3730550866963327,0.02764688365817239,['PTPN6'],0.9999639263661667,0,0,1
477,Trans-sulfuration and one-carbon metabolism WP2525,0.9285701151203776,0.3730550866963327,0.02764688365817239,['AHCY'],0.9999639263661667,0,0,1
478,16p11.2 proximal deletion syndrome WP4949,0.9289664621345741,0.5709262645877717,0.04206735548161252,"['CASP8', 'KCTD13', 'ALDOA', 'SEZ6L2', 'CDIPT']",0.9999639263661667,0,0,5
479,Ciliopathies WP4803,0.9338642729612336,0.6872388693040867,0.047023748771419994,"['DNAH11', 'DCDC2', 'AK7', 'GLI3', 'GLI2', 'TMEM17', 'EVC', 'MAK', 'NME9', 'HYDIN', 'CCDC65', 'CCNQ', 'CCDC151', 'DNAI1']",0.9999639263661667,0,0,14
480,7q11.23 copy number variation syndrome WP4932,0.9346502204883128,0.604054574776292,0.04082376923565089,"['CLDN5', 'ATP5MC3', 'VPS37D', 'UBE2L6', 'GTF2IRD1', 'ACACB', 'ATP5MC1']",0.9999639263661667,0,0,7
481,Vitamin D-sensitive calcium signaling in depression WP4698,0.9347839405637082,0.4427873395565928,0.029861514421624873,"['CALB1', 'PVALB']",0.9999639263661667,0,0,2
482,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9374065664833807,0.3543731778425656,0.022906040276502174,['TRPC3'],0.9999639263661667,0,0,1
483,TLR4 Signaling and Tolerance WP3851,0.9374065664833807,0.3543731778425656,0.022906040276502174,['TLR4'],0.9999639263661667,0,0,1
484,Type II interferon signaling (IFNG) WP619,0.9374065664833807,0.3543731778425656,0.022906040276502174,['PRKCD'],0.9999639263661667,0,0,1
485,AMP-activated protein kinase (AMPK) signaling WP1403,0.939104583315911,0.5244461751471097,0.03295012909213058,"['STRADB', 'LEPR', 'HMGCR', 'ACACB']",0.9999639263661667,0,0,4
486,Regulatory circuits of the STAT3 signaling pathway WP4538,0.939104583315911,0.5244461751471097,0.03295012909213058,"['PDGFRB', 'DUSP2', 'IL5RA', 'IL6ST']",0.9999639263661667,0,0,4
487,Leptin signaling pathway WP2034,0.9394509547610987,0.5529934979544127,0.03453978865439669,"['CCND1', 'CFL2', 'LEPR', 'BAX', 'ACACB']",0.9999639263661667,0,0,5
488,EGF/EGFR signaling pathway WP437,0.9397030064361923,0.6707527720510392,0.041715056792256226,"['MAP4K1', 'VAV3', 'JUN', 'EGF', 'PRKCD', 'GAB1', 'FOXO4', 'PLD1', 'RPS6KA5', 'PTK2B', 'SPRY2', 'FOSB', 'ARF6']",0.9999639263661667,0,0,13
489,Wnt Signaling Pathway WP363,0.9410787390170972,0.48284508836172585,0.02932244201589128,"['GCKR', 'CCND1', 'ROR2']",0.9999639263661667,0,0,3
490,EPO Receptor Signaling WP581,0.9451504010818588,0.337470498403443,0.01903711900850935,['EPOR'],0.9999639263661667,0,0,1
491,Nanoparticle triggered autophagic cell death WP2509,0.9451504010818588,0.337470498403443,0.01903711900850935,['MAP1LC3A'],0.9999639263661667,0,0,1
492,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.9451504010818588,0.337470498403443,0.01903711900850935,['ADAMTS2'],0.9999639263661667,0,0,1
493,G13 Signaling Pathway WP524,0.9474912655650681,0.41667238657423294,0.022474292046622258,"['CFL2', 'IQGAP2']",0.9999639263661667,0,0,2
494,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9474912655650681,0.41667238657423294,0.022474292046622258,"['CNGB3', 'CYCS']",0.9999639263661667,0,0,2
495,Cardiac Hypertrophic Response WP2795,0.9513940166591324,0.4617756795857763,0.023008889393367607,"['MAP4K1', 'TGFB1', 'EGF']",0.9999639263661667,0,0,3
496,Cell migration and invasion through p75NTR WP4561,0.9519366501447402,0.32210442618605883,0.01586583019806614,['JUN'],0.9999639263661667,0,0,1
497,Ectoderm Differentiation WP2858,0.9521400757239789,0.6060758222445393,0.029723847248498938,"['MAFB', 'BOC', 'SPRY2', 'ROR2', 'NR2F2', 'ARHGAP15', 'JAKMIP1', 'PTPN13', 'GLI3']",0.9999639263661667,0,0,9
498,Kit receptor signaling pathway WP304,0.9558948904783692,0.4519134031374595,0.020384602114208193,"['TEC', 'PTPN6', 'JUNB']",0.9999639263661667,0,0,3
499,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9558948904783692,0.4519134031374595,0.020384602114208193,"['NDUFA7', 'NDUFB10', 'NDUFB11']",0.9999639263661667,0,0,3
500,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9558948904783692,0.4519134031374595,0.020384602114208193,"['MAVS', 'CASP8', 'TMEM173']",0.9999639263661667,0,0,3
501,Toll-like Receptor Signaling Pathway WP75,0.9571881911281457,0.4881163390267483,0.0213576572827753,"['JUN', 'TICAM2', 'CASP8', 'TLR4']",0.9999639263661667,0,0,4
502,PDGF Pathway WP2526,0.9578152227289269,0.39345909503435755,0.01695824350148921,"['PDGFRB', 'JUN']",0.9999639263661667,0,0,2
503,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9578836655794808,0.30807453416149067,0.01325612158929158,['BMP2'],0.9999639263661667,0,0,1
504,Translation Factors WP107,0.9600030476452375,0.4424620548744892,0.01806077892822195,"['EIF4A2', 'EEF1G', 'EIF3I']",0.9999639263661667,0,0,3
505,Ras signaling WP4223,0.9622357470224714,0.6233947804473903,0.023998080205419534,"['PDGFRB', 'SHC4', 'HTR7', 'SHC3', 'GAB1', 'CALM3', 'FOXO4', 'PLD1', 'FGFR4', 'ETS1', 'RASGRP3', 'ARF6']",0.9999639263661667,0,0,12
506,Wnt signaling in kidney disease WP4150,0.9630951791350881,0.29521379980563656,0.01110093514128872,['WNT16'],0.9999639263661667,0,0,1
507,Regulation of toll-like receptor signaling pathway WP1449,0.9658197927803863,0.5238899718431882,0.01821985177407008,"['JUN', 'TICAM2', 'CASP8', 'PELI3', 'PTPN6', 'TLR4']",0.9999639263661667,0,0,6
508,Nanoparticle-mediated activation of receptor signaling WP2643,0.9676621077752895,0.28338192419825076,0.009315419837187816,['FN1'],0.9999639263661667,0,0,1
509,Chemokine signaling pathway WP3929,0.9694523812315731,0.5543922487027598,0.017199422068265503,"['SHC4', 'VAV3', 'HCK', 'SHC3', 'PRKCD', 'PTK2B', 'DOCK2', 'CXCL14']",0.9999639263661667,0,0,8
510,Histone Modifications WP2369,0.9697356558442871,0.36310325225144363,0.011158803591305107,"['SET', 'H3F3B']",0.9999639263661667,0,0,2
511,Prolactin Signaling Pathway WP2037,0.9728093871210741,0.44919151461207535,0.012382915589818575,"['JUN', 'TEC', 'PTPN6', 'YWHAG']",0.9999639263661667,0,0,4
512,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9729316302967215,0.3539964994165694,0.00971418296474139,"['MAP1LC3A', 'CP']",0.9999639263661667,0,0,2
513,MET in type 1 papillary renal cell carcinoma WP4205,0.9756734248203494,0.4005551333311304,0.0098646131767711,"['JUN', 'GAB1', 'ETS1']",0.9999639263661667,0,0,3
514,CAMKK2  Pathway WP4874,0.9782442134505774,0.25295710120783005,0.0055640274789405635,['MAP1LC3A'],0.9999639263661667,0,0,1
515,RANKL/RANK signaling pathway WP2018,0.9783738664192613,0.3370839584375174,0.007369803268860172,"['JUN', 'CALCR']",0.9999639263661667,0,0,2
516,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9806812586460019,0.3292176603077257,0.006422307976455048,"['RPS6KA5', 'IL1R1']",0.9999639263661667,0,0,2
517,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9812713876219287,0.4222346212860929,0.007982858032432594,"['EDN1', 'TGFB1', 'EGF', 'IL6ST']",0.9999639263661667,0,0,4
518,Integrin-mediated Cell Adhesion WP185,0.9814808293122999,0.45321374514828633,0.008471832756215797,"['VAV3', 'SHC3', 'CAV3', 'ITGB4', 'MYPN']",0.9999639263661667,0,0,5
519,MAPK Cascade WP422,0.9832968283050783,0.23605442176870747,0.003976157985559376,['JUN'],0.9999639263661667,0,0,1
520,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9853645507234801,0.2284209536349102,0.00336774809109873,['GABRD'],0.9999639263661667,0,0,1
521,Interferon type I signaling pathways WP585,0.986258913744499,0.30767084369133985,0.004257047276368677,"['RPS6KA5', 'PTPN6']",0.9999639263661667,0,0,2
522,IL-1 signaling pathway WP195,0.9902558185645128,0.2887624127830829,0.0028275519138060297,"['JUN', 'IL1R1']",0.9999639263661667,0,0,2
523,Fragile X Syndrome  WP4549,0.9913287732340462,0.4576479639381921,0.003985674701365928,"['HOMER1', 'PRKAR1A', 'CDKN2A', 'GAD1', 'GAB1', 'PPP2R5B', 'GABRD']",0.9999639263661667,0,0,7
524,DNA Repair Pathways Full Network WP4946,0.9920256063920441,0.4534117811263629,0.0036301775558308935,"['BRIP1', 'FEN1', 'NEIL2', 'RPA3', 'POLE2', 'APEX1', 'POLE3']",0.9999639263661667,0,0,7
525,Thermogenesis WP4321,0.9925135146498921,0.40138010732692203,0.0030162309182780044,"['ADCY10', 'CREB3', 'PRDM16', 'ACSL5', 'ACTG1']",0.9999639263661667,0,0,5
526,G Protein Signaling Pathways WP35,0.9935307152924635,0.36235921399472804,0.002351820448699699,"['PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD']",0.9999639263661667,0,0,4
527,Splicing factor NOVA regulated synaptic proteins WP4148,0.9949163731247286,0.18144576511923452,0.0009247551195897658,['NTNG1'],0.9999639263661667,0,0,1
528,Ciliary landscape WP4352,0.9958622474937705,0.524470585293897,0.0021746316315761137,"['DOCK5', 'EXOC8', 'DYNLT3', 'COPS7A', 'RAB3IL1', 'IQGAP2', 'DYNLL2', 'PSMD8', 'EXOSC4', 'TTC30B', 'ERF', 'TMED1', 'COPS8', 'GLA']",0.9999639263661667,0,0,14
529,Genes related to primary cilium development (based on CRISPR) WP4536,0.9964751072450873,0.36768824274303524,0.0012983512440532027,"['TMEM17', 'EVC', 'TTC30B', 'CDK20', 'TULP3']",0.9999639263661667,0,0,5
530,Energy Metabolism WP1541,0.9973749689901639,0.16076066790352506,0.00042255659345399345,['PPP3R2'],0.9999639263661667,0,0,1
531,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9976999657468532,0.15717525105280208,0.0003619248406707458,['HOMER1'],0.9999639263661667,0,0,1
532,Joubert Syndrome WP4656,0.9989519915659053,0.20775276271535453,0.00021784081698764072,"['TMEM17', 'PDE6B']",0.9999639263661667,0,0,2
533,mRNA Processing WP411,0.9997030749786848,0.29111582323420165,8.645240759574773e-05,"['NCBP2', 'DDX20', 'CSTF2T', 'SNU13', 'SRSF9']",0.9999639263661667,0,0,5
534,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9999639263661667,0.18694109077383259,6.74376609377656e-06,"['MAP4K1', 'RPS6KA5', 'SHC3']",0.9999639263661667,0,0,3
